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Figure SA 
Sequences 2 3 4 5 6 7 8 9 10 
1 RDA13 1.00 0.32 0.25 0.52 0.36 0.28 0.79 0.60 0.60 0.34 
2RDA1 0.34 1.00 0.65 0.31 0.44 0.49 0.38 0.36 0.40 0.61 
3 RDA2 0.25 0.63 1.00 0.24 0.39 0.38 0.27 0.26 0.30 0.53 
4 RDAlO 0.53 0.35 0.24 1.00 0.26 0.21 0.49 0.47 0.48 0.29 
5RDA5 0.42 0.48 0.47 0.30 1.00 0.59 0.41 0.48 0.38 0.70 
6RDA4 0.34 0.56 0.48 0.24 0.60 1.00 0.33 0.26 0.34 0.79 
7RDA 0.82 0.34 0.28 0.48 0.36 0.27 1.00 0.67 0.63 0.37 
8 RDA12 0.59 0.36 0.30 0.48 0.42 0.23 0.66 1.00 0.56 0.33 
9 RDAll 0.63 0.40 0.33 0.50 0.35 0.31 0.68 0.60 1.00 0.42 
10 RDA6 0.42 0.72 0.66 0.34 0.71 0.79 0.45 0.38 0.48 1.00 
11 RDA8 0.38 0.34 0.25 0.30 0.32 0.42 0.42 0.39 0.29 0.37 
12 RDA7 0.42 0.30 0.28 0.26 0.26 0.27 0.35 0.32 0.35 0.31 
13 RDA9 0.48 0.19 0.28 0.34 0.25 0.29 0.48 0.40 0.34 0.31 
14 RDA3 0.39 0.68 0.64 0.34 0.66 0.86 0.38 0.35 0.47 0.90 
15 RDA15 0.38 0.34 0.34 0.25 0.34 0.37 0.40 0.36 0.39 0.37 
16 RDA17 0.23 0.12 0.14 0.12 0.18 0.18 0.16 0.10 0.22 0.16 
17 RDA16 0.33 0.28 0.17 0.27 0.25 0.28 0.29 0.26 0.32 0.26 
18 RdhAlsAvI 0.65 0.44 0.32 0.56 0.33 0.27 0.56 0.69 0.55 0.37 
19 RdhA2BAVI 0.36 0.40 0.37 0.25 0.32 0.40 0.38 0.25 0.42 0.42 
20 RdhA3BAVI 0.39 0.30 0.28 0.29 0.29 0.33 0.34 0.30 0.42 0.36 
21 RdhA4BAVT 0.36 0.64 0.85 0.25 0.45 0.43 0.31 0.27 0.27 0.53 
22 RdhA5BAVI 0.42 0.67 0.66 0.29 0.74 0.78 0.42 0.40 0.50 1.00 
23 RdhA6BAVI 0.43 0.61 0.57 0.35 0.37 0.54 0.30 0.35 0.37 0.63 
24 RdhA 7BAVT 0.69 0.37 0.36 0.52 0.38 0.25 0.65 0.75 0.68 0.34 
25 TCEA 0.44 0.50 0.50 0.33 0.43 0.49 0.35 0.34 0.36 0.48 
26 PCEA 0.22 0.22 0.17 0.20 0.20 0.22 0.22 0.28 0.28 0.20 
27 PCEAb 0.26 0.13 0.17 0.17 0.19 0.16 0.17 0.20 0.20 0.12 
28 PCEAc 0.26 0.13 0.17 0.17 0.18 0.16 0.17 0.20 0.20 0.12 
29 PCEAd 0.26 0.13 0.17 0.17 0.18 0.16 0.17 0.20 0.20 0.12 
30 CPRAd 0.31 0.22 0.22 0.25 0.25 0.26 0.26 0.29 0.29 0.24 
31 CPRAc 0.27 0.21 0.25 0.24 0.27 0.27 0.28 0.27 0.24 0.26 
32 CprAh 0.32 0.20 0.21 0.25 0.25 0.25 0.28 0.30 0.29 0.23 
33 CprAV 0.31 0.22 0.21 0.25 0.25 0.26 0.26 0.29 0.29 0.25 
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Figure SB 
Sequences 11 12 13 14 15 16 17 18 19 20 
1 RDA13 0.38 0.43 0.46 0.32 0.38 0.22 0.24 0.64 0.34 0.42 
2RDA1 0.36 0.32 0.21 0.59 0.36 0.12 0.23 0.44 0.38 0.34 
3RDA2 0.25 0.29 0.26 0.51 0.37 0.13 0.15 0.31 0.36 0.34 
4 RDAlO 0.30 0.28 0.33 0.29 0.25 0.11 0.19 0.55 0.23 0.31 
5RDA5 0.37 0.32 0.28 0.65 0.41 0.20 0.23 0.39 0.37 0.36 
6RDA4 0.49 0.33 0.33 0.85 0.48 0.22 0.26 0.31 0.44 0.42 
7RDA 0.41 0.35 0.45 0.31 0.41 0.16 0.23 0.54 0.35 0.36 
8 RDA12 0.40 0.33 0.38 0.33 0.38 0.09 0.20 0.66 0.25 0.33 
9 RDAll 0.30 0.38 0.35 0.42 0.43 0.23 0.23 0.57 0.43 0.48 
10 RDA6 0.44 0.38 0.37 0.90 0.50 0.22 0.25 0.43 0.47 0.47 
11 RDA8 1.00 0.42 0.50 0.42 0.42 0.21 0.26 0.39 0.40 0.47 
12 RDA7 0.41 1.00 0.39 0.34 0.39 0.15 0.18 0.29 0.24 0.34 
13 RDA9 0.52 0.41 1.00 0.31 0.37 0.17 0.25 0.34 0.32 0.28 
14 RDA3 0.51 0.42 0.38 1.00 0.48 0.18 0.30 0.42 0.47 0.50 
15 RDA15 0.39 0.39 0.34 0.36 1.00 0.21 0.19 0.35 0.37 0.37 
16 RDAl 7 0.22 0.16 0.18 0.13 0.22 1.00 0.31 0.16 0.20 0.22 
17 RDA16 0.33 0.25 0.35 0.31 0.25 0.41 1.00 0.25 0.38 0.35 
18 RdhAlsAvI 0.39 0.30 0.33 0.36 0.38 0.16 0.18 1.00 0.31 0.40 
19 RdhA2nAVT 0.42 0.26 0.33 0.42 0.40 0.20 0.31 0.33 1.00 0.53 
20 RdhA3sAvI 0.44 0.34 0.26 0.39 0.36 0.19 0.25 0.38 0.47 1.00 
21 RdhA4BAVI 0.33 0.33 0.26 0.55 0.41 0.13 0.22 0.35 0.43 0.36 
22 RdhA5BAVI 0.43 0.40 0.31 0.90 0.53 0.25 0.25 0.42 0.51 0.48 
23 RdhA6sAv1 0.47 0.41 0.26 0.58 0.40 0.17 0.25 0.38 0.48 0.47 
24 RdhA 7sAvI 0.41 0.40 0.36 0.34 0.38 0.15 0.22 0.58 0.33 0.34 
25 TCEA 0.53 0.34 0.25 0.54 0.44 0.31 0.28 0.41 0.42 0.36 
26PCEA 0.37 0.25 0.26 0.24 0.28 0.30 0.28 0.22 0.27 0.24 
27 PCEAb 0.25 0.19 0.15 0.15 0.24 0.26 0.29 0.17 0.20 0.23 
28 PCEAc 0.25 0.21 0.15 0.15 0.22 0.26 0.29 0.17 0.20 0.23 
29 PCEA<l 0.25 0.19 0.15 0.15 0.22 0.26 0.29 0.17 0.20 0.23 
30 CPRAd 0.29 0.24 0.26 0.32 0.29 0.33 0.36 0.32 0.41 0.27 
31 CPRAc 0.27 0.30 0.28 0.35 0.35 0.31 0.35 0.31 0.38 0.26 
32 CprAh 0.30 0.21 0.30 0.33 0.29 0.35 0.38 0.33 0.41 0.25 
33 CprAV 0.29 0.22 0.26 0.32 0.29 0.33 0.36 0.32 0.41 0.27 
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Figure SC 
Sequences 21 22 23 24 25 26 27 28 29 30 
1 RDA13 0.36 0.34 0.33 0.72 0.37 0.22 0.24 0.24 0.24 0.26 
2RDA1 0.66 0.55 0.49 0.42 0.43 0.23 0.12 0.12 0.12 0.21 
3RDA2 0.84 0.53 0.47 0.37 0.42 0.17 0.18 0.18 0.18 0.18 
4 RDAlO 0.25 0.24 0.27 0.56 0.29 0.20 0.17 0.17 0.17 0.20 
5RDA5 0.55 0.72 0.34 0.45 0.45 0.25 0.21 0.20 0.20 0.25 
6RDA4 0.52 0.78 0.53 0.33 0.50 0.27 0.19 0.19 0.19 0.26 
7RDA 0.31 0.35 0.23 0.67 0.29 0.23 0.16 0.16 0.16 0.25 
8 RDA12 0.31 0.34 0.30 0.82 0.32 0.28 0.18 0.18 0.18 0.26 
9 RDAll 0.29 0.45 0.32 0.75 0.33 0.29 0.19 0.19 0.19 0.26 
10 RDA6 0.65 1.00 0.60 0.44 0.52 0.26 0.14 0.14 0.14 0.23 
11 RDA8 0.34 0.36 0.40 0.41 0.44 0.37 0.24 0.24 0.24 0.25 
12 RDA7 0.30 0.32 0.31 0.41 0.28 0.24 0.17 0.19 0.17 0.19 
13 RDA9 0.27 0.27 0.23 0.38 0.23 0.26 0.13 0.13 0.13 0.20 
14 RDA3 0.68 0.90 0.58 0.44 0.56 0.30 0.18 0.18 0.18 0.31 
15 RDA15 0.37 0.40 0.30 0.35 0.36 0.26 0.22 0.21 0.21 0.22 
16 RDA17 0.13 0.18 0.16 0.17 0.26 0.30 0.25 0.25 0.25 0.29 
17 RDA16 0.28 0.26 0.24 0.31 0.31 0.34 0.35 0.35 0.35 0.40 
18 RdhAlsAvr 0.33 0.35 0.32 0.63 0.36 0.22 0.16 0.16 0.16 0.28 
19 RdhA2sAvr 0.46 0.44 0.41 0.37 0.38 0.28 0.19 0.19 0.19 0.38 
20 RdhA3BAVI 0.32 0.37 0.34 0.31 0.29 0.22 0.21 0.21 0.21 0.22 
21 RdhA4sAvr 1.00 0.54 0.47 0.40 0.46 0.21 0.15 0.14 0.15 0.22 
22 RdhA5sAVI 0.69 1.00 0.62 0.46 0.52 0.26 0.16 0.16 0.16 0.25 
23 RdhA6sAvr 0.58 0.62 1.00 0.51 0.68 0.36 0.16 0.16 0.16 0.23 
24 RdhA 7sAvr 0.38 0.34 0.39 1.00 0.33 0.26 0.18 0.18 0.18 0.31 
25 TCEA 0.54 0.49 0.62 0.43 1.00 0.39 0.31 0.31 0.31 0.31 
26 PCEA 0.22 0.20 0.29 0.27 0.35 1.00 0.33 0.33 0.33 0.36 
27 PCEAb 0.15 0.13 0.13 0.18 0.28 0.34 1.00 1.00 1.00 0.31 
28 PCEAc 0.13 0.13 0.13 0.20 0.28 0.34 1.00 1.00 1.00 0.31 
29 PCEAd 0.15 0.13 0.13 0.18 0.28 0.34 1.00 1.00 1.00 0.31 
30 CPRAd 0.27 0.26 0.22 0.35 0.32 0.41 0.35 0.35 0.35 1.00 
31 CPRAc 0.33 0.25 0.24 0.32 0.34 0.42 0.40 0.40 0.40 0.99 
32 CprAh 0.26 0.24 0.20 0.36 0.31 0.42 0.37 0.37 0.37 1.00 
33 CprAV 0.27 0.26 0.22 0.35 0.32 0.41 0.35 0.35 0.35 1.00 
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Figure SD 
Sequences 31 32 33 
1 RDA13 0.23 0.27 0.26 
2 RDAl 0.18 0.20 0.21 
3RDA2 0.21 0.18 0.18 
4 RDAlO 0.19 0.20 0.20 
5 RDA5 0.25 0.25 0.25 
6RDA4 0.27 0.25 0.26 
7RDA 0.25 0.24 0.25 
8 RDA12 0.24 0.27 0.26 
9 RDAll 0.20 0.26 0.26 
10 RDA6 0.25 0.22 0.24 
11 RDA8 0.22 0.26 0.25 
12 RDA7 0.22 0.17 0.18 
13 RDA9 0.22 0.25 0.20 
14 RDA3 0.34 0.32 0.31 
15 RDA15 0.28 0.23 0.22 
16 RDAl 7 0.27 0.31 0.29 
17 RDA16 0.38 0.41 0.40 
18 RdhAlnAVI 0.27 0.29 0.28 
19 RdhA2nAVI 0.35 0.37 0.38 
20 RdhA3nAVI 0.20 0.21 0.22 
21 RdhA4nAVI 0.26 0.21 0.22 
22 RdhA5nAVI 0.24 0.22 0.26 
23 RdhA6nAv1 0.24 0.21 0.22 
24 RdhA7nAVI 0.25 0.31 0.31 
25 TCEA 0.33 0.30 0.31 
26 PCEA 0.36 0.36 0.36 
27 PCEAb 0.37 0.34 0.31 
28 PCEAc 0.37 0.34 0.31 
29 PCEAd 0.37 0.34 0.31 
30 CPRAd 0.98 0.98 1.00 
31 CPRAc 1.00 0.96 0.99 
32 CprAh 0.96 1.00 1.00 
33 CprAV 0.98 0.98 1.00 
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Figure 6A 
* 40 * 
SFDS---E2$DIPPSSVDP : 52 
SFEA---EPSWSIPPSAIAT : 52 
~~!e!!SFEE---E;;;PAG----- : 47 
DQGS---E~FPASMYKP : 52 
PYDK---EPSWELPTLYGKP : 52 
SYDK---Eii&rTPSKYAP : 52 
SKEK---EPSWoIPLTEGKE : 52 
QERGI--oR.§ioNNc-GQSW : 52 
PAKGV--NRNWoSNCDGQSF : 53 
G----DK~!oNAC-GQDW : 50 
QVG----PfQISNNR----W : 47 
SHE----GPRiloSPH----W : 47 
EQG----og§}iATQ---PG : 48 
EKG----D~~TQ---PG : 48 
PG----E~DDN---AF : 48 
KTG----D~DDT---IY : 48 
: 48 
SKE---TKLIJIDIVQAYDS- : 51 
: 53 
,~~~~·~PT---FRE~ITPADDAN : 52 
PTKEEMKEJiiiRSTGPWSS : 55 
Ca CP 
* 
SMET---EQQ~PACTG--- : 49 
SKEA---E~PTGVW--- : 49 
: 46 
SHEK---DFKVLQPEDCEVA : 52 
SHEK---DgKVLQPEDCEVA : 52 
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Figure 6D 
RDA13 PEKWEE;;DKD-YPVLGQDSTIGSYYGGY-------- :159 
RDA AEETS!]IDLS-LPLYGQDGSIGATDGGYK------- : 161 
RDAll HHD~~DLD-LPRYGFDTTMGVRDGGYGK------ :150 
RDA12 GOEKE EIG-LPAYGFDTTVGSTVGGY-------- :160 
RDhAlBAVl GEEKED!iiDLS-LPSMGWDTTSFSKHGGY-------- :155 
RDhA7BAVl ESEWNN!iiDMN-LPAYAFDTTVGVTDGGYKAKGLLQQ :168 
RDAlO AEKAET~LS-LPTLGQDSTITAADGGYGK------ :158 
RDA2 DKDPAS SP-DEWFIYGTHPNLLRQ---------- :160 
RDhA4BAVl DKDPES!iiHEP-NAWHVYGSNPGLLG----------- :158 
RD Al HKEPES~LPLEQIPAYGVNPALLVK --------- :154 
RDhA6BAVl KDDLND QSHKPW---------------------- :128 
TCEA SPSRDE~SE-NPIRGASVDIF-------------- :137 
RDA6 RKDPRD -IDDYTYGINTSY--------------- :133 
RDhA5BAVl RKDPRD -IDDYTYGINTSY--------------- :133 
RDA3 RKNPAT!iiDEVDDYPYGVDTSY--------------- :133 
RDA4 RKDQRD~K-EEDFPFGIDTSY--------------- :134 
RDA5 RKPQWE D-IEQPTYGFDTTA--------------- :136 
RDA8 DT-IEE!iiTN---SFPVNGIHYDNDAYYN-------- :157 
RDA9 DQ-iiE~LG-EKMPIBGI----------------- :153 
RDA7 QNMWD FEPDKYWPLEGIETNL------------- :163 
RDA15 DEERST TGNMAEWGIHQYGKNEW------------ :163 
RDhA2BAVl RLN---~RDLNTWQYDD-VFGMGTKDPKSWL---- :154 
RDhA3BAVl NVSPDE RDLKTYPFKGRVMGDG------WA---- :168 
PCEA KRNITE DGKINTYGLDADHFRDTVSFRKDRVKKS- :155 
PCEAc PVNPDERLESGYVQNMVKDFWNNPESIKQ-------- : 151 
PCEAd PVNPDERLESGYVQNMVKDFWNNPESIKQ-------- : 151 
PCEAb PVNPDERLESGYVQNMVKDFWNNPESIKQ-------- : 151 
CPRAd TIEK~LEWPEKYPLKPM----------------- :137 
CprAV TIEK~LEWPEKYPLKPM----------------- :137 
CprAh TIEK~LEWPEKYVMK------------------- :135 
CPRAc TIDK~EWPELYKIQ------------------- :135 
RDA16 EGHATGE PWR------------------------- :126 
RDA17 VYEPP~IQTNEYVSSFVNTPMGVK------------ :155 
w 
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ISOLATED REDUCTIVE DEHALOGENASE 
GENES 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application is a divisional application of U.S. patent 
application Ser. No. 11/575,156, filed Mar. 13, 2007, which is 
a U.S. national phase application of PCT/US05/33063, filed 
Sep. 14, 2005, which in tum claims the benefit of U.S. Pro-
visional Patent Application 60/609,892, all of which are 
incorporated herein by reference. 
REFERENCE TO A SEQUENCE LISTING 
This application includes a Sequence Listing submitted 
electronically as a text file named SequenceListingl 67 44.txt, 
created on Jun. 4, 2010, with a size of 56,000 bytes. The 
sequence listing is incorporated by reference. 
FIELD OF THE INVENTION 
The invention relates to novel reductive dehalogenase 
genes encoding reductive dehalogenases that have been iso-
lated from dechlorinating bacteria. The invention also relates 
to methods of detecting and characterizing reductively 
dechlorinating populations of bacteria possessing the novel 
dehalogenase genes of the invention. 
BACKGROUND OF THE INVENTION 
Vinyl chloride (VC) is a toxic and carcinogenic priority 
pollutant that threatens drinking water quality in most indus-
trialized countries. Kielhom J., at al. (2000) Environ. Health 
Perspect. 108:579-588. A major source of environmental VC 
is due to transformation reactions acting on chlorinated sol-
vents such as tetrachloroethene (PCE) and trichloroethene 
(TCE), which are abundant groundwater pollutants. Mohn 
W., at al. (1992) Microbial. Rev. 56:482-507. Additional envi-
ronmental VC pollution originates from landfills, PVC pro-
duction facilities and abiotic formation in soils. Due to the 
extent of the problem, innovative and affordable technologies 
are needed to restore VC contaminated sites and guarantee 
drinking water safety. 
Bioremediation approaches that rely on the activity of bac-
terial populations that use chlorinated compounds as growth-
supporting electron acceptors (i.e., chlororespiration) have 
been used previously in the field (see, e.g., Ellis D., et al. 
(2000) Environ. Sci. Technol. 34:2254-2260; Major, D., et al. 
(2002) Environ. Sci. Technol. 36:5106-5116; Lendvay J., et 
al. (2003) Environ. Sci. Technol. 37:1422-1431). Bacterial 
populations useful in bioremediation include bacteria capable 
2 
Although 16S rRNA gene-based PCR approaches have 
been developed to detect and quantify members of Dehalo-
coccoides, such approaches are limited in their applicability 
as Dehalococcoides strains with different dechlorination 
5 activities share similar or identical 16S rRNA gene 
sequences. He, J. eta!. (2003)Nature 424:62-65. Examples of 
Dehalococcoides strains which demonstrate substantial simi-
larities among 16S rRNA gene sequences, but distinct dechlo-
rination activities include Dehalococcoides sp. strain 
10 CBDBl, which dechlorinates trichlorobenzenes, pentachlo-
robenzene and some polychlorinated dibenzodioxin conge-
ners but failed to dechlorinate PCE and TCE (Adrian, et al. 
(2000) Nature 408:580-583), Dehalococcoides ethenogenes 
195 andDehalococcoides sp. andDehalococcoides sp. strain 
15 FL2, which grow with polychlorinated ethenes as electron 
acceptors but cannot grow with VC, andDehalococcoides sp. 
strain BAVl which respires all DCE isomers and VC (He, J. et 
al. (2003) Nature 424:62-65). Despite their metabolic differ-
ences, these strains share 16S rRNA gene sequences with 
20 more than 99.9% similarity (based on the analysis of 1,296 
aligned positions). He, J. et al. (2003) Appl. Environ. Micro-
bial. 65:485-495. 
As a result of the high degree of identity among the 16S 
rRNA gene sequences of various Dehalococcoides popula-
25 tions, the identification of bacteria having different dechlori-
nating activities is difficult. There is, therefore, a need in the 
art for an improved means of identifying and characterizing 
reductively dechlorinating populations of bacteria. One such 
approach is to identify genes associated with the dechlorina-
30 ti on of particular halogenated compounds, particularly genes 
encoding for reductive dehalogenases (RDases) capable of 
reductive dehalogenation ofVC. 
Gene sequences encoding for reductive dehalogenases 
involved in the partial reductive dechlorination of PCE and 
35 chlorinated aromatic compounds have been identified (see 
e.g., Magnuson, J., et al. (2000) Appl. Environ. Microbial. 
66:51441-5147). Functional genes involved in complete 
reduction ofVC, however, have not been found. Alignment of 
known reductive dehalogenase amino acid sequences 
40 revealed low sequence identity (27 to 32%); although con-
served stretches have been identified, e.g., a twin diarginine 
(RR) motif nearthe amino-terminus and two iron-sulfur clus-
ter binding motifs near the C-terminus. Additionally, each of 
the identified RDase genes is associated with a B gene that 
45 encodes a hydrophobic protein with transmembrane helices 
believed to anchor the RDase to the membrane. Magnuson, J., 
et al. (2000) Appl. Environ Microbial. 66:51441-5147. In 
Dehalococcoides, Sulfurospirillum (formerly Dehalospiril-
lum ), Dehalobacter and Desulfitobacterium, the B gene is 
50 located downstream of the PCE/TCE RDase genes. See e.g., 
Magnuson, J., et al. (2000) Appl. Environ. Microbial. 
66:51441-5147; Maillard, J., et al. (2003) Appl. Environ. 
Microbial. 69:4628-4638; Suyama, A., et al. (2002) J. Bat-
eriaol. 184:3419-3425. In cprA operons (ortho chlorophenol 
of reductive dechlorination and detoxification of VC to 
ethene. Such bacterial populations include members of the 
family Dehalococcoides, a deeply branching group on the 
bacterial tree most closely affiliated with the Chlorofiexi. 
Cupples A., at al. (2003) Appl. Environ. Micobiol. 69:953-
959. To facilitate the identification of bacterial populations 
responsible for dechlorination and detoxification ofVC, 16S 
rRNA gene-based PCR approaches have been designed to 60 
detect and quantify members of Dehalococcoides. Such 
approaches have been helpful for assessing VC-contaminated 
sites, monitoring bioremediation efforts, and establishing 
cause-effect relationships between the presence of chlori-
nated compounds and the growth of specific strains of dechlo- 65 
rinating bacteria. Lendvay J ., et al. (2003) Environ. Sci. Tech-
nol. 37:1422-1431. 
55 RDases) of Desulfitobacterium species an opposite arrange-
ment was observed. Van de Pas, B., et al. (2003)J. Biol. Chem. 
52:299-312. 
Although gene sequences encoding reductive dehalogena-
ses involved in the partial reductive dechlorination of PCE 
and chlorinated aromatic compounds have been identified, 
genes encoding enzymes capable of reductive dechlorination 
of vinyl chloride to ethene, have not been identified. Hence, 
there is a need in the art to identify functional genes associ-
ated with VC reductive dechlorination and in particular to 
identify and isolate reductive dehalogenase genes from 
dechlorinating bacteria and in particular those of the family 
Dehalococcoides. Additionally, there is a need in the art for a 
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method of that identifies reductively dechlorinating popula-
tions ofbacteria which overcomes the limitations of the iden-
tification methods of the prior art, and facilitate the monitor-
ing ofbioremediation by dechlorinating bacteria. 
SUMMARY OF THE INVENTION 
The present invention provides novel reductive dehaloge-
nase genes isolated from dechlorinating bacteria and encod-
ing for reductive dehalogenase enzymes. The deduced amino 
acid sequences of the presently identified dehalogenase 
enzymes indicates that they are capable of the reductive deha-
logenation of halogenated substrates and in particular the 
reduction of vinyl chloride to ethene. 
In certain embodiments, the invention provides for meth-
ods of identifying and isolating bacterial target DNA from 
dechlorinating bacteria of interest, such as Dehalococcoides 
populations. 
In additional embodiments, the invention provides gene 
primer pairs and probes useful for quantification of dechlori-
nating bacteria using analytical techniques such as, for 
example and without limitation, hybridization, PCR and 
Real-Time PCR technology. The components provided and 
the methods in which they are employed are useful in biore-
mediation processes mediated by dechlorinating bacteria. 
4 
selected from the group consisting of SEQ ID NO: 9-15; and 
(iii) a second primer comprising a portion of any one of the 
sequences selected from the group consisting of SEQ ID NO: 
16-22; and (b) performing Real-Time PCR on the sample to 
quantify the amount of dechlorinating bacteria present in the 
sample. 
In another embodiment, the invention provides a method of 
detecting the presence of a dechlorinating bacteria in a 
sample comprising, (a) contacting the sample with (i) a first 
10 primer comprising a portion of any one of the sequences 
selected from the group consisting of SEQ ID NO: 9-15; and 
(ii) a second primer comprising a portion of a sequence 
selected from the group consisting of SEQ ID NO: 16-22; and 
(b) performing PCR on the sample, wherein the presence of 
15 amplification products confirms the presence of the dechlo-
rinating bacteria. 
In another embodiment, the invention provides a method 
for identifying a dechlorinating bacterial organism compris-
ing the steps of (a) contacting a probe with a bacterial cell 
20 extract, the contact effecting the hybridization with a nucleic 
acid derived from the bacterial cell extract, wherein the probe 
comprises the polynucleotide claim 1, or a fragment thereof, 
and, (b) determining that the probe has hybridized to the 
nucleic acid derived from the bacterial cell extract. 
25 
In still another embodiment, the invention provides for an 
isolated polynucleotide encoding a reductive dehalogenase 
comprising a polynucleotide sequence having at least 85% 
and preferably at least 90% and more preferably at least 95% 
and still more preferably 99% sequence identity over the 30 
length of the entire reference sequence to a polynucleotide 
consisting of a sequence selected from the group consisting of 
SEQ ID NO: 1-8. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows a schematic of the bvcA gene and its corre-
sponding B gene showing conserved features shared with 
other known reductive dehalogenase genes and their associ-
ated B genes. Conserved dehalogenase features are labeled 
with an asterisk. 
FIG. 2 shows the results of PCR amplification of the bvcA 
gene with specific primers bvcAF and bvcAR and templates 
generated from VC-grown BAVl cultures and cis-DCE 
grown cultures of Dehalococcoides sp. strain FL2. 
In other embodiments, the invention provides a recombi-
nant expression vector comprising any one of the aforemen- 35 
tioned isolated polynucleotides operably linked to a regula-
tory sequence, and a cell, or organism comprising the 
recombinant gene sequence. 
FIG. 3 shows the results of an experiment demonstrating 
the specificity of primers targeting the VC RDase gene, bvcA. 
In another embodiment, the invention provides a vector 
comprising any one of the aforementioned isolated poly- 40 
nucleotides. 
FIG. 4 shows the detection ofbvcA in VC-dechlorinating 
mixed cultures. 
FIGS. SA-SD show the alignment of the amino acid 
sequences deduced from the BvcA gene of the present inven-
tion and other known reductive dehalogenases isolated from 
D. ethenogenes strain 195 and Dehalococcoides sp. strain 
In still another embodiment, the invention provides an 
isolated polynucleotide encoding an enzyme that reductively 
dechlorinates vinyl chloride. In a preferred embodiment, the 
invention provides an isolated polynucleotide encoding a 
reductive dehalogenase. 
In yet another embodiment, the invention provides an iso-
lated polynucleotide encoding an enzyme that reductively 
dechlorinates vinyl chloride wherein the polynucleotide is 
isolated from dechlorinating bacteria, such as for example, 
Dehalococcoides sp. strain BAVl. 
In another embodiment, the present invention provides a 
method of identifying a polynucleotide encoding a reductive 
dehalogenase in a sample, comprising: contacting the sample 
with (i) a first oligonucleotide primer comprising a portion of 
the polynucleotide of claim 1; and (ii) a second oligonucle-
otide primer comprising a portion of the polynucleotide of 
claim 1; and performing PCR on the sample, wherein the 
presence of an amplification product indicates the presence of 
a polynucleotide encoding a reductive dehalogenase in the 
sample. 
In another embodiment the invention provides a method of 
quantifying the amount of dechlorinating bacteria present in 
45 BAVl. RDA (1-17) correspond to the deduced amino acid 
sequences of D. ethenogenes strain 195 reductive dehaloge-
nases (Villemur et. al. (2002) J. Can. Microbial. 48:697-706, 
TceA) corresponds to D. ethenogenes strain 195 trichlore-
thene dehalogenase (AF228507-2), PceA corresponds to tet-
50 rachloroethene dehalogenase of Delzalospirllum nzul-
tivorans (AF022812.1), PceAb corresponds to 
tetrachloroethene dehalogenase of Desulfitobacterium sp. 
Y51. (21623559), PceAc corresponds to tetrachloroethene 
dehalogenase of Dehalobacter restrictus (AJ439607.1), 
55 PceAd corresponds to tetrachloroethene dehalogenase of 
Desulfitobacterium frappieri (AJ439608.1 ), CprAd corre-
sponds to o-chlorophenol dehalogenase precursor of Desulfi-
tobacterium dehalogenans (AFl 15542-3), CprAc corre-
sponds to o-chlorophenol dehalogenase of 
60 Desulfitobacterium chlororespirans (AF204275.2), CprAh 
corresponds to o-chlorophenol dehalogenase of Desulfito-
bacterium hafniense (AF4031828), CprAV corresponds to 
o-chlorophenol reductive dehalogenase of Desulfitobacte-
a sample comprising, (a) contacting the sample with (i) a 
probe comprising a portion of any one of the sequences 65 
selected from the group consisting of SEQ ID NO: 1-8; (ii) a 
first primer comprising a portion of any one of the sequences 
rium sp. Viet-1 (AF259791.1). 
FIGS. 6A-6D are an aligrnnentmatrix corresponding to the 
alignment of the deduced amino acid sequences from Deha-
lococcoides sp. strain BAVl reductive dehalogenase genes, 
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including bvcA, of the present invention and other known 
reductive dehalogenases isolated from Dehalococcoides 
ethenogenes strain 195, Dehalospirllum multivorans (PceA), 
Desulfitobacterium sp. Y51 (PceAb), Dehalobacter restric-
tus (PceAc ), Desulfitobacteriunz frappieri (PceAd), Desulfi-
tobacterium dehalogenans (CprAd, CprAc ), Desulfitobacte-
rium hafniense (CprAh) and Desulfitobacterium sp. Viet-1 
(CprAV). 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention is directed to novel reductive deha-
logenase genes encoding for reductive dehalogenases which 
are capable of dehalogenating organic compounds. The genes 
and proteins they encode may be useful in the bioremediation 
of pollutants. In particular embodiments, the invention pro-
vides the complete sequence of a novel vinyl chloride deha-
logenase gene (bvcA) having the polynucleotide sequence of 
SEQ ID NO: 1. The novel vinyl chloride dehalogenase gene 
encodes a reductive dehalogenase that is capable of the com-
plete reduction of vinyl chloride to ethene. 
The present invention further provides for a method of 
identifying dechlorinating bacterial populations capable of 
facilitating the reductive dechlorination of organic com-
pounds and in particular the identification of vinyl chloride 
respiring dechlorinating bacterial populations. Such methods 
include, but are not limited to, the identification of dechlori-
nating bacterial populations via the identification of reductive 
dehalogenase genes, using such methods as hybridization, 
PCR and Real-Time PCR. Moreover, such methods may be 
used to assess and monitor dechlorinating bacterial popula-
tions at sites contaminated with halogenated compounds and 
which are amenable to bioremediation using dechlorinating 
bacteria. 
Definitions and Abbreviations 
The term reductive dehalogenase is abbreviated "RDase." 
The term Real-Time PCR is abbreviated as "RTm PCR" 
and as used herein means a method for simultaneous ampli-
fication, detection, and quantification of a target polynucle-
otide using double dye-labeled fluorogenic oligodeoxyribo-
nucleotide probes during PCR. 
As used herein, the terms "PCE," "perchloroethylene," 
"tetrachloroethylene," and "tetrachloroethene" are synony-
mous and refer to Cl2C=CC12 
As used herein, "TCE," "trichloroethylene," and "trichlo-
roethene" are synonymous and refer to Cl2 C=CH--Cl. 
As used herein, "DCE," "dichloroethylene," and "dichlo-
roethene" are synonymous and refer to Cl-HC=CH--Cl. 
As used herein, "VC, "vinyl chloride," and "chloroethene" 
are synonymous and refer to H2C=CH--Cl. 
As used herein, "ethylene" and "ethene" are synonymous 
and refer to H2C=CH2 . 
As used herein, the term "chloroethenes" refers to PCE, 
TCE, DCE, VC, and mixtures thereof. 
"Reductive dehalogenase enzyme" refers to an enzyme 
system that is capable of dehalogenating a halogenated 
straight chain or ring containing organic compound, that con-
tains at least one halogen atom. Examples of halogenated 
organic compounds that may de-halogenated by a reductive 
dehalogenase include, but not limited to, PCE, TCE, DCEs 
(cis-DCE, trans-DCE, 1,1-DCE)_ and VC. 
"Dechlorinating bacteria" refers to a bacterial species or 
organism population that has the ability to remove at least one 
chlorine atom from a chlorinated organic compound. 
Examples of dechlorinating bacteria include, but are not lim-
ited to Delzalococcoides spp, Dehalobacter restrictus, Sulfu-
6 
rospirillum multivorans, Desulfitobacteriunz dehalogenans, 
Desulfuromonas chloroethenica, andDesulfuromonas michi-
ganensis. 
As referred to herein, "sequence similarity" means the 
extent to which nucleotide or protein sequences are related. 
The extent of similarity between two sequences can be based 
on percent sequence identity and/or conservation. With 
regard to proteins, sequence identity is a comparison of exact 
amino acid matches, whereas sequence similarity refers to 
10 amino acids at a position that have the same physical-chemi-
cal properties (i.e. charge, hydrophobicity). Amino acids 
other than those indicated as conserved may differ in a protein 
or enzyme so that the percent protein or amino acid sequence 
similarity between any two proteins of similar function may 
15 vary. Preferably, the sequence identity is at least 30%, pref-
erably at least 50%, more preferably at least 70%, even more 
preferably 80%, and most preferably at least 90%, as deter-
mined according to an alignment scheme. 
"Sequence alignment" means the process oflining up two 
20 or more sequences to achieve maximal levels of sequence 
identity (and, in the case of amino acid sequences, conserva-
tion), e.g., for the purpose of assessing the degree of sequence 
similarity. Methods for aligning sequences and assessing 
similarity and/or identity are well known in the art. Such 
25 methods include for example, the MEGALIGN software 
Clustal Method, wherein similarity is based on the MEGA-
LIGN Clustal algorithm, ClustalW and ClustalX (Thompson, 
J., et al. (1997) Nucleic Acid Res. 25:4876-4882) as well as 
BLASTN, BLASTP, and PASTA (Pearson et al. (1988) Proc 
30 Natl. Acad. Sci USA. 85:2444-2448). When using these pro-
grams, the preferred settings are those that result in the high-
est sequence similarity. 
Molecular Biology 
In accordance with the present invention there may be 
35 employed conventional molecular biology, microbiology, 
and recombinant DNA techniques within the skill of the art. 
The general genetic engineering tools and techniques dis-
cussed herein, including transformation and expression, the 
use of host cells, vectors, expression systems, etc., are well 
40 known in the art. See, e.g., Sambrook, Fritsch & Maniatis, 
Molecular Cloning: A Laboratory Manual, Third Edition 
(2001) Cold Spring Harbor Laboratory Press, Cold Spring 
Harbor, N.Y. (herein "Sambrook et al. 2001 ");DNA Cloning: 
A Practical Approach, Volumes I and II, Second Edition (D. 
45 N. Glover ed. 1995); B. Perbal, A Practical Guide To Molecu-
lar Cloning (1984); F. M. Ausubel et al. (eds.), Current Pro-
tocols in Molecular Biology, John Wiley & Sons, Inc. (1994). 
The term "host cell" means any cell of any organism that is 
selected, modified, transformed, grown, used, or manipulated 
50 in any way, for the production of a substance by the cell, for 
example the expression by the cell of a gene in this cell, a 
DNA or RNA sequence, a protein or an enzyme. 
A "polynucleotide" or "nucleotide sequence" is a series of 
nucleotide bases (also called "nucleotides") in DNA and 
55 RNA, and means any chain of two or more nucleotides. A 
nucleotide sequence typically carries genetic information, 
including the information used by cellular machinery to make 
proteins and enzymes. These terms include double or single 
stranded genomic and cDNA, RNA, any synthetic and geneti-
60 cally manipulated polynucleotides, and both sense and anti-
sense polynucleotides (although only sense stands are being 
represented herein). This includes single- and double-
stranded molecules, i.e., DNA-DNA, DNA-RNA and RNA-
RNA hybrids, as well as "protein nucleic acids" (PNAs) 
65 formed by conjugating bases to an amino acid backbone. This 
also includes nucleic acids containing modified bases, for 
example thio-uracil, thio-guanine and fluoro-uracil. 
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Polynucleotides may be flanked by natural regulatory 
sequences, or may be associated with heterologous 
sequences, including promoters, enhancers, response ele-
ments, signal sequences, polyadenylation sequences, intrans, 
5'- and 3'-non-coding regions, and the like, and may be modi-
fied by many means known in the art. 
The term "gene", means a DNA sequence that codes for or 
corresponds to a particular sequence of amino acids which 
comprise all or part of one or more proteins or enzymes, and 
may or may not include regulatory DNA sequences, such as 10 
promoter sequences, which determine, for example, the con-
ditions under which the gene is expressed. 
A "coding sequence" or a sequence "encoding" a polypep-
tide, protein or enzyme is a nucleotide sequence that, when 
15 
expressed, results in the production of that polypeptide, pro-
tein or enzyme, i.e., the nucleotide sequence encodes an 
amino acid sequence for that polypeptide, protein or enzyme. 
Preferably, the coding sequence is a double-stranded DNA 
sequence that is transcribed and translated into a polypeptide 20 
in a cell in vitro or in vivo when placed under the control of 
appropriate regulatory sequences. The boundaries of the cod-
ing sequence are determined by a start codon at the 5' (amino) 
terminus and a translation stop codon at the 3' (carboxyl) 
terminus. A coding sequence can include, but is not limited to, 25 
prokaryotic sequences, cDNA from enkaryotic mRNA, 
genomic DNA sequences from eukaryotic (e.g., mammalian) 
DNA, and even synthetic DNA sequences. If the coding 
sequence is intended for expression in a eukaryotic cell, a 
polyadenylation signal and transcription termination 30 
sequence will usually be located 3' to the coding sequence. 
Transcriptional and translational control sequences are 
DNA regulatory sequences, such as promoters, enhancers, 
terminators, and the like, that provide for the expression of a 
35 
coding sequence in a host cell. In eukaryotic cells, polyade-
nylation signals are control sequences. 
A "promoter sequence" is a DNA regulatory region 
capable of binding RNA polymerase in a cell and initialing 
transcription of a downstream (3' direction) coding sequence. 40 
For purposes of defining this invention, the promoter 
sequence is bounded at its 3' terminus by the transcription 
initiation site and extends upstream (5' direction) to include 
the minimum number of bases or elements necessary to ini-
tiate transcription at levels detectable above background. As 45 
described above, promoter DNA is a DNA sequence which 
initiates, regulates, or otherwise mediates or controls the 
expression of the coding DNA. A promoter may be "induc-
ible", meaning that it is influenced by the presence or amount 
8 
or produced in a foreign host cell under the control of a 
foreign or native promoter, or in a native host cell under the 
control of a foreign promoter. 
The term "transformation" means the introduction of a 
"foreign" (i.e. extrinsic or extracellular) gene, DNA or RNA 
sequence to a host cell, so that the host cell will express the 
introduced gene or DNA fragment to produce a desired sub-
stance, typically a protein or enzyme coded by the introduced 
gene or sequence. The introduced gene or sequence, which 
may also be called a "cloned" or "foreign" gene or sequence, 
may include regulatory or control sequences, such as start, 
stop, promoter, signal, secretion, or other sequences used by 
a cell's genetic machinery. The gene or sequence may include 
nonfunctional sequences or sequences with no known func-
tion. A host cell that receives and expresses introduced DNA 
or RNA has been "transformed" and is a "transformant" or a 
"clone." The DNA or RNA introduced to a host cell can come 
from any source, including cells of the same genus or species 
as the host cell, or cells of a different genus or species. 
The terms "vector", "cloning vector" and "expression vec-
tor" mean the vehicle by which a DNA or RNA sequence 
(e.g., a foreign gene) can be introduced into a host cell, so as 
to transform the host and promote expression (e.g., transcrip-
tion and translation) of the introduced sequence. 
A common type of vector is a "plasmid", which generally 
is a self-replicating molecule of double-stranded DNA. A 
plasmid can readily accept additional (foreign) DNA and 
which can readily be introduced into a suitable host cell. A 
plasmid vector often contains coding DNA and promoter 
DNA and has one or more restriction sites suitable for insert-
ing foreign DNA. Promoter DNA and coding DNA may be 
from the same gene or from different genes, and may be from 
the same or different organisms. A large number of vectors, 
including plasmid vectors, have been described for replica-
tion and/or expression in a variety of enkaryotic and prokary-
otic hosts. Non-limiting examples include pKK plasmids 
(Clontech), pUC plasmids, pET plasmids (Novagen, Inc., 
Madison, Wis.), pRSET or pREP plasmids (Invitrogen, San 
Diego, Calif.), or pMAL plasmids (New England Biolabs, 
Beverly, Mass.), and many appropriate ho st cells, using meth-
ods disclosed or cited herein or otherwise known to those 
skilled in the relevant art. Recombinant cloning vectors will 
often include one or more replication systems for cloning or 
expression, one or more markers for selection in the host, e.g. 
antibiotic resistance, and one or more expression vectors. 
Routine experimentation in biotechnology can be used to 
determine which vectors are best suited for used with the 
present invention. In general, the choice of vector depends on 
the size of the polynucleotide sequence and the host cells to be 
of another compound (an "inducer"). For example, an induc-
ible promoter includes those that initiate or increase the 
expression of a downstream coding sequence in the presence 
50 used. 
of a particular inducer compound. A "leaky" inducible pro-
moter is a promoter that provides a high expression level in 
the presence of an inducer compound and a comparatively 55 
very low expression level, and at minimum a detectable 
expression level, in the absence of the inducer. 
The terms "express" and "expression" mean allowing or 
causing the information in a gene or DNA fragment to 
become manifest, for example producing a protein by acti- 60 
vating the cellular functions involved in transcription and 
translation of a corresponding gene or DNA sequence. A 
DNA sequence is expressed in or by a cell to form an "expres-
sion product" such as a protein. The expression product itself, 
e.g., the resulting protein or enzyme, may also be the to be 65 
"expressed" by the cell. A polynucleotide or polypeptide is 
expressed recombinantly, for example, when it is expressed 
The term "expression system" means a host cell and com-
patible vector under suitable conditions, e.g. for the expres-
sion of a protein coded for by foreign DNA carried by the 
vector and introduced to the host cell. Common expression 
systems include bacteria (e.g., E. coli and B. subtilis) or yeast 
(e.g., S. cerevisiae) host cells and plasmid vectors, and insect 
host cells and Baculovirus vectors. As used herein, a "facile 
expression system" means any expression system that is for-
eign or heterologous to a selected polynucleotide or polypep-
tide, and which employs host cells that can be grown or 
maintained more advantageously than cells that are native or 
heterologous to the selected polynucleotide or polypeptide, 
or which can produce the polypeptide more efficiently or in 
higher yield. For example, the use of robust prokaryotic cells 
to express a protein of eukaryotic origin would be a facile 
expression system. Preferred facile expression systems 
include E. coli, B. subtilis, and S. cerevisiae, and reductively 
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dechlorinating populations that are easy to cultivate (e.g., 
Anaeronzyxobacter dehalogenans strains and Desulfitobac-
terium species) as host cells and for any suitable vector. 
"Sequence-conservative variants" of a polynucleotide 
sequence are those in which a change of one or more nucle-
otides in a given codon position results in no alteration in the 
amino acid encoded at that position. 
10 
dehalogenases (RDases ). In one embodiment, the invention 
provides polynucleotide fragments useful for the isolation of 
RDase genes by aligning conserved regions of full-length 
protein and DNA sequences ofTceA and RDases. Examples 
of such primers are shown in Table 1, below. 
TABLE 1 
"Isolation" or "purification" of a polypeptide, protein or 
enzyme refers to the derivation of the polypeptide by remov-
ing it from its original environment (for example, from its 10 
natural environment if it is naturally occurring, or form from 
the host cell if it is produced by recombinant DNA methods). 
Methods for polypeptide purification are well known in the 
art, including, without limitation, preparative disc-gel elec-
trophoresis, isoelectric focusing, HPLC, reversed-phase 15 
HPLC, gel filtration, ion exchange, hydrophobic interaction, 
affinity, and partition chromatography, and countercurrent 
distribution. For some purposes, it is preferable to produce the 
polypeptide in a recombinant system in which the protein 
contains an additional sequence tag that facilitates purifica- 20 
ti on, such as, but not limited to, a poly histidine sequence. The 
polypeptide can then be purified from a crude lysate of the 
host cell by chromatography on an appropriate solid-phase 
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The invention also provides PCR primer pairs and probes 
useful in the identification of RDase genes, as well as a 
number of polynucleotide fragments encoding at least a por-
tion of several RDases. The PCR primer pairs, probes and 
polynucleotide fragments of the present invention may be 
used to isolate cDNAs and genes encoding homologous pro-
or against peptides derived therefrom can be used as purifi- 25 
cation reagents. Other purification methods are possible. A 
purified polynucleotide or polypeptide may contain less than 
about 50%, preferably less than about 7 5%, and most prefer-
ably less than about 90%, of the cellular components with 
which it was originally associated. A "substantially pure" 30 
enzyme indicates the highest degree of purity that can be 
achieved using conventional purification techniques known 
teins from the same or other dechlorinating bacteria species. 
Isolation of homologous genes using sequence-dependent 
protocols is well known in the art. Examples of sequence-
dependent protocols include, but are not limited to, methods 
of nucleic acid hybridization, and methods of DNA and RNA 
amplification as exemplified by various uses of nucleic acid 
amplification technologies (e.g., PCR, ligase chain reaction). 
For example, genes encoding other RDases, either as 
cDNAs or genomic DNAs, could be isolated directly by using 
all or a portion of the instant polynucleotide fragments as 
in the art. 
Polynucleotides are "hybridizable" to each other when at 
least one strand of one polynucleotide can anneal to another 
polynucleotide under defined stringency conditions. Strin-
gency ofhybridization is determined, e.g., by the temperature 
at which hybridization and/or washing is performed, and b) 
the ionic strength and polarity (e.g., formamide) of the 
hybridization and washing solutions, as well as other param-
eters. Hybridization requires that the two polynucleotides 
contain substantially complementary sequences; depending 
on the stringency of hybridization, however, mismatches may 
be tolerated. Typically, hybridization of two sequences at 
high stringency (such as, for example, in an aqueous solution 
of 0.5xSSC at 65° C.) requires that the sequences exhibit 
some high degree of complementarity over their entire 
sequence. Conditions of intermediate stringency (such as, for 
example, an aqueous solution of 2xSSC at 65° C.) and low 
stringency (such as, for example, an aqueous solution of 
2xSSC at 55° C.), require correspondingly less overall 
complementarity between the hybridizing sequences. 
(lxSSCis0.15 MNaCl, 0.015 MNacitrate.)Polynucleotides 
that "hybridize" to the polynucleotides herein may be of any 
length. In one embodiment, such polynucleotides are at least 
10, preferably at least 15 and most preferably at least 20 
nucleotides long. In another embodiment, polynucleotides 
that hybridize are of about the same length. In another 
embodiment, polynucleotides that hybridize include those 
which armeal under suitable stringency conditions and which 
encode polypeptides, proteins or enzymes having the same 
function, such as the ability to catalyze an oxidation, oxyge-
nase, or coupling reaction. 
Identification of RDase Genes 
In certain embodiments, the present invention provides 
polynucleotide fragments which may be useful as primers 
and probes for the identification of genes encoding reductive 
35 DNA hybridization probes to screen libraries from any 
desired dechlorinating bacterial population employing meth-
odology well known to those skilled in the art. Specific oli-
gonucleotide probes based upon the instant nucleic acid 
sequences can be designed and synthesized by methods 
40 known in the art (see, e.g., Sambrook, et al. 2001). Moreover, 
an entire sequence can be used directly to synthesize DNA 
probes by methods known to the skilled artisan such as ran-
dom primer DNA labeling, nick translation, end-labeling 
techniques, or RNA probes using available in vitro transcrip-
45 tion systems. In addition, specific primers can be designed 
and used to amplify a part or all of the instant sequences. The 
resulting amplification products can be labeled directly dur-
ing amplification reactions or labeled after amplification 
reactions, and used as probes to isolate full length cDNA or 
50 genomic fragments under conditions of appropriate strin-
gency. 
In addition, two short segments of the instant polynucle-
otide fragments may be used in PCR protocols to amplify 
longer nucleic acid fragments encoding homologous genes 
55 from DNA or RNA. The PCR may also be performed on a 
library of cloned nucleic acid fragments to identify nucleotide 
sequences encoding bacterial reductive dehalogenases. 
Alternatively, the second primer sequence may be based 
upon sequences derived from the cloning vector. For 
60 example, the skilled artisan can follow the RACE protocol 
(Frohman et al. (1988) Proc. Natl. Acad. Sci. 85:8998-9002) 
to generate cDNAs by using PCR to amplify copies of the 
region between a single point in the transcript and the 3' or 5' 
end. Primers oriented in the 3' and 5' directions can be 
65 designed from the instant sequences. Using commercially 
available 3' RACE or 5' RACE systems, specific 3' or 5' cDNA 
fragments can be isolated (Ohara et al. (1989) Proc. Natl. 
US 8,278,092 B2 
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Acad. Sci. 86:5673-5677; Loh et al. (1989) Science 243:217-
220). Products generated by the 3' and 5' RACE procedures 
can be combined to generate full-length cDNAs (Frohman 
and Martin (1989) Techniques 1:165). Consequently, a poly-
nucleotide comprising a nucleotide sequence of about at least 5 
about 30 contiguous nucleotides derived from a nucleotide 
sequence selected from the group consisting of SEQ ID NO: 
1-8 and the complement of such nucleotide sequences may be 
used in such methods to obtain a nucleic acid fragment encod-
ing a substantial portion of an amino acid sequence of a 10 
polypeptide. 
Identification, Use and Expression ofRDase Polypeptides 
In certain additional embodiments, the present invention 
provides a method of obtaining a polynucleotide fragment 
encoding a RDase polypeptide, preferably a substantial por- 15 
tion of a RDase polypeptide, comprising the steps of: (i) 
synthesizing a pair of oligonucleotide primers comprising, 
wherein each oligonucleotide primer comprises preferably at 
least about 10, more preferably at least about 15, and still 
more preferably at least about 25 contiguous nucleotides 20 
derived from a nucleotide sequence selected from the group 
consisting of SEQ ID NO: 1-8; and (ii) amplifying a poly-
nucleotide fragment (preferably a cDNA inserted in a cloning 
vector) using the oligonucleotide primer pair. The amplified 
polynucleotide fragment preferably will encode a portion of a 25 
RDase polypeptide that occurs between the two primers. 
In one embodiment, the availability of the instant nucle-
otide and deduced amino acid sequences facilitates immuno-
logical screening of cDNA expression libraries. Synthetic 
peptides representing portions of the instant amino acid 30 
sequences may be synthesized. These peptides can be used to 
immunize animals to produce polyclonal or monoclonal anti-
bodies with specificity for peptides or proteins comprising the 
amino acid sequences. These antibodies can be then be used 
to screen cDNA expression libraries to isolate full-length 35 
cDNA clones of interest (see e.g., Sambrook et al. 2001 ). 
In another embodiment, this invention concerns viruses 
and host cells comprising either the recombinant expression 
vectors as described herein or an any one of the isolated 
polynucleotides of the present invention described herein. 40 
Examples of host cells which can be used to practice the 
present invention include, but are not limited to, yeast, bac-
teria and insect. 
Plasmid vectors comprising the instant isolated polynucle-
otide may be constructed. The choice of plasmid vector is 45 
dependent upon the method that will be used to transform a 
host organism, e.g., yeast, bacterial cell or insect. The skilled 
artisan is well aware of the genetic elements that must be 
present on the plasmid vector in order to successfully trans-
form, select and propagate host cells containing the recom- 50 
binant expression vector. The skilled artisan will also recog-
nize that different independent transformation events will 
result in different levels and patterns of expression (Jones et 
al. (1985) EMBO J 4:2411-2418; De Almeida et al. (1989). 
Mal. Gen. Genetics 218:78-86), and thus that multiple events 55 
must be screened in order to obtain lines displaying the 
desired expression level and pattern. Such screening may be 
accomplished by Southern analysis of DNA, Northern analy-
sis of mRNA expression, Western analysis of protein expres-
sion, or phenotypic analysis. 60 
Genetic Mapping 
The isolated polynucleotides of the present invention may 
be used as probes forthe genetic and physical mapping of the 
genes they are a part of, and may further be used as markers 
for traits linked to those genes. Such information may be 65 
useful in the art to identify and develop strains of dechlori-
nating bacteria capable of reducing vinyl and other chloroor-
12 
ganic contaminants. For example, the instant polynucleotide 
fragments may be used as probes to detect restriction frag-
ment length polymorphisms (RFLPs) that identify bacterial 
populations with the dechlorinating activity of interest. 
Southern blots (see, e.g., Sambrook, et al. 2001) ofrestric-
tion-digested bacterial genomic DNA may be probed with the 
polynucleotide fragments of the instant invention. The result-
ing banding patterns may then be subjected to genetic analy-
ses using computer programs such as MapMaker (Lander et 
al. (1987) Genomics 1: 174-181) to construct a genetic map. 
The isolated polynucleotide fragments may also be used to 
probe Southern blots containing restriction endonuclease-
treated genomic DNAs of a set of individuals representing 
parent and progeny of a defined genetic cross. Segregation of 
the DNA polymorphisms is noted and used to calculate the 
position of the instant polynucleotide sequence in the genetic 
map previously obtained using this population (Botstein et al. 
(1980)Am. J. Hum. Genet. 32:314-331). 
Additionally, the isolated polynucleotides of the present 
invention may be used in a variety of polynucleotide ampli-
fication-based methods of genetic and physical mapping. 
Examples include allele-specific amplification (Kazazian 
(1989) J. Lab. Clin. Med. 11:95-96), polymorphism of PCR-
amplified fragments (CAPS; Sheffield et al. (1993) Genomics 
16:325-332), allele-specific ligation (Landegren et al. (1988) 
Science 241:1077-1080), nucleotide extension reactions 
(Sokolov (1990) Polynucleotide Res. 18:3671), Radiation 
Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) 
and Happy Mapping (Dear and Cook (1989) Polynucleotide 
Res. 17:6795-6807). For these methods, the sequence of a 
polynucleotide fragment is used to design and produce primer 
pairs for use in the amplification reaction or in primer exten-
sion reactions. The design of such primers is well known to 
those skilled in the art. In methods employing PCR-based 
genetic mapping, it may be necessary to identify DNA 
sequence differences between the parents of the mapping 
cross in the region corresponding to the instant polynucle-
otide sequence. This, however, is generally not necessary for 
mapping methods. 
Hybridization Techniques for the Detection of Dechlorinat-
ing Bacteria 
In another embodiment, the invention provides a method of 
detecting dechlorinating bacteria using the polynucleotides 
disclosed herein as hybridization probes. The probe length 
can vary from 5 bases to thousands of bases. Preferably how-
ever, the probe is at least 10, more preferably at least 15 and 
most preferably at least 20 nucleotides in length. Probes may 
also be, for example, about 100, 200, 300, 400, or 500 nucle-
otides in length. Only part of the probe molecule need be 
complementary to the nucleic acid sequence to be detected 
and the complementary portion need not be identical. Hence, 
all or part of the aforementioned lengths may be complemen-
tary to the polynucleotide sequence to be detected. The probe 
may be RNA or DNA or a synthetic nucleic acid. In each 
instance a probe will contain a sequence sufficiently comple-
mentary to the nucleic acid from the dechlorinating bacteria 
to be detected, and that will permit hybridization between the 
probe and the subject DNA. 
In certain embodiments the probe is a polynucleotide that 
is substantially complementary to a fragment or the entire the 
polynucleotide sequence of a gene encoding a RDase. In 
preferred embodiment, the probe may be selected from a 
fragment or the an entire polynucleotide selected from the 
group consisting of SEQ ID NO: 1-8. More preferably, the 
probe is selected from a fragment or the entire polynucleotide 
of SEQ ID NO: 1. 
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ment, and buffers for the disbursement and lysis of the 
sample. A second component may include media in either dry 
or liquid form for the hybridization of target and probe poly-
nucleotides, as well as for the removal of undesirable and 
nonduplexed forms by washing. A third component includes 
a solid support (dipstick) upon which is fixed or to which is 
conjugated unlabeled nucleic acid probe(s) that is (are) 
complementary to a part of a nucleic acid encoding for a 
reductive dehalogenase of the species of bacteria being 
Hybridization methods are well known in the art (see, e.g., 
Sambrook, et al. 2001). Typically, the probe and sample are 
mixed under conditions that permit nucleic acid hybridiza-
tion. This involves contacting the probe and sample in the 
presence of an inorganic or organic salt under the proper 
concentration and temperature conditions. The probe and 
sample nucleic acids must be in contact for a sufficient time 
that any possible hybridization between the probe and sample 
nucleic acid may occur. The concentration of probe or target 
in the mixture will determine the time necessary for hybrid-
ization to occur. The higher the probe or target concentration, 
the shorter the hybridization incubation time needed. 
10 tested. 
In certain embodiments, hybridization assays may be con-
ducted directly on bacterial lysates, without the need to 
extract the nucleic acids. This eliminates several steps from 15 
the sample-handling process and speeds up the assay. To 
perform such assays on crude cell lysates, a chaotropic agent 
PCR Based Detection of Dechlorinating Bacteria 
In an another embodiment, the polynucleotides of the 
present invention may be used as primers in primer directed 
nucleic acid amplification, i.e., PCR, to detect the presence of 
the target gene(s) in the dechlorinating wild type bacteria. 
Methods of PCR primer design are well known in the art (see, 
e.g., Sambrook, et al. 2001; Herndon, Va.; and Rychlik, W. 
(1993) In White, B. A. (ed.), Methods in Molecular Biology, 
Vol. 15, pp 31-39, PCR Protocols: Current Methods and 
Applications. Humania Press, Inc., Totowa, N.J., see also, 
U.S. Pat. Nos. 4,683,195; 4,683,2020; 4,965,188; and 4,800, 
159, which are hereby incorporated by reference). 
Typically, detection of dechlorinating bacteria using PCR 
involves the amplification of DNA or cDNA obtained from a 
sample suspected of having dechlorinating activity. The iso-
lated DNA or cDNA (from mRNA) is amplified using a pair 
of oligonucleotide primers having regions complementary to 
only one of the stands in the target. A primer refers to an 
oligonucleotide that can be extended with a DNA polymerase 
is typically added to the cell lysates prepared as described 
above. The chaotropic agent stabilizes nucleic acids by inhib-
iting nuclease activity. Furthermore, the chaotropic agent 20 
allows sensitive and stringent hybridization of short oligo-
nucleotide probes to RNA at room temperature (Van Ness and 
Chen (1991) Nucl. Acids Res. 19:5143-5151). Suitable chao-
tropic agents include guanidinium chloride, guanidinium 
thiocyanate, sodium thiocyanate, lithium tetrachloroacetate, 25 
sodium perchlorate, rubidium tetrachloroacetate, potassium 
iodide, and cesium trifluoroacetate, among others. Typically, 
the chaotropic agent will be present at a final concentration of 
about 3 M. If desired, one can add formamide to the hybrid-
ization mixture, typically 30-50% (v/v). 
Various hybridization solutions can be employed. Typi-
cally, these comprise from about 20 to 60% volume, prefer-
ably 30%, of a polar organic solvent. A common hybridiza-
tion solution comprises about 30-50% v/v formamide, about 
0.15 to 1 M sodium chloride, about 0.05 to 0.1 M buffer, such 35 
as sodium citrate, Tris-HCl, PIPES or HEPES (pH range 
about 6-9), about 0.05 to 0.2% detergent, such as sodium 
dodecylsulfate, and between 0.5-20 mM EDTA, FICOLL™ 
(Amersham Biosciences, Piscataway, N.J.) (about 300-500 
kDa), polyvinylpyrrolidone (about 250-500 kDa), and serum 40 
albumin. Also included in the typical hybridization solution, 
will be from about 0.1 to 5 mg/ml, unlabeled carrier nucleic 
acids, e.g., fragmented calf thymus or salmon sperm DNA, or 
yeast RNA, and optionally from about 0.5 to 2% wt/vol gly-
cine. Other additives may also be included, such as volume 45 
exclusion agents which include a variety of polar water-
soluble or swellable agents, such as polyethylene glycol, 
anionic polymers such as polyacrylate orpolymethylacrylate, 
and anionic saccharidic polymers, such as dextran sulfate. 
30 using monodeoxyribonucleoside triphosphates and a nucleic 
acid that is used as a template. This primer preferably has a 3' 
hydroxyl group on an end that is facing the 5' end of the 
template nucleic acid when it is hybridized with the template. 
Hybridization is adaptable to a variety of assay formats. 50 
One of the most suitable is the sandwich assay format. The 
sandwich assay is particularly adaptable to hybridization 
under non-denaturing conditions. A primary component of a 
sandwich-type assay is a solid support. The solid support has 
adsorbed to it or covalently coupled to it immobilized nucleic 55 
acid probe that is unlabeled and complementary to one por-
tion of the nucleic acid to be detected, e.g., nucleic acid 
encoding for a reductive dehalogenase. Preferred are those 
probes are those described above. Probes particularly useful 
in the present embodiment are those polynucleotides which 60 
are substantially complementary to a fragment or the entire 
the polynucleotide sequence of a gene encoding a RDase, and 
in particular to those which are substantially complementary 
to any one of the sequences of SEQ ID NO: 1-8. 
The sandwich assay may be encompassed in an assay kit. A 65 
kit may include a first component for the collection of 
samples from soil or groundwater, such as vials for contain-
A set of primers refers to a combination or mixture of at 
least a first (forward) and a second (reverse) primer. The first 
primer can be extended using the template nucleic acid while 
forming an extension product in such a way that the second 
primer can hybridize with this extension product in a region 
of the extension product that lies in the 3' direction of the 
extendable end of the first primer. The extendable end of the 
second primer points in the 5' direction of the extension 
product of the first primer. Examples of primers that are 
suitable for performing the polymerase chain reaction (PCR) 
and that meet this definition are described in European Patent 
Application No. 0201184, which is hereby incorporated by 
reference. Typical amplicons range in size from 25 by to 2000 
by (see, e.g., U.S. Pat. No. 6,518,025). Larger sized ampli-
cons can be obtained, typically using specialized conditions 
or modified polymerases. 
The primers of the present invention are designed to be 
specific to regions of the bvcA genes identified herein. Useful 
primers include, but are not limited to, those having the poly-
nucleotide sequence of any one of SEQ ID NO: 9-22. In a 
preferred embodiment the first primer is the polynucleotide of 
SEQ ID NO.: 14 and the second primer is the polynucleotide 
of SEQ ID NO: 21. 
Following amplification, the products of PCR may be 
detected using any one of a variety of PCR detection methods 
are known in the art including standard non-denaturing gel 
electrophoresis (e.g., acrylamide or agarose ), denaturing gra-
dient gel electrophoresis, and temperature gradient gel elec-
trophoresis. Standard non-denaturing gel electrophoresis is 
the simplest and quickest method of PCR detection, but may 
not be suitable for all applications. 
Real Time PCR Based Detection of Dechlorinating Bacteria 
In yet another embodiment, the invention provides a 
method of detecting dechlorinating bacteria using Real-Time 
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PCR protocols known in the art, such as the RTm PCR pro-
tocol described in U.S. Provisional Application No. 60/474, 
831, which is hereby incorporated by reference. During the 
course of PCR the fluorescent signal generated by the reac-
PCR ("RTm PCR"). RTm PCR is a further enhancement to 
the standard PCR, described above. RTm-PCR allows con-
temporaneous quantification of a sample of interest, for 
example a bacteria population having a polynucleotide 
sequence of interest. 
In RTm PCR, a fluorogenically labeled oligonucleotide 
probe is used in addition to the primer sets which are 
employed in standard PCR. The probe, in RTm PCR anneals 
to a sequence on the target DNA found between a first (for-
ward, 5'primer) and second (reverse, 3' primer) PCR primer 
binding sites and consists of an oligonucleotide with a 5'-re-
porter dye (e.g., FAM, 6-carboxyfluorescein) and a quencher 
dye (e.g., TAMRA, 6-carboxytetramethylrhodamine) which 
quenches the emission spectra of the reporter dye as long as 
both dyes are attached to the probe. The probe signals the 
formation of PCR amplicons by a process involving the poly-
merase-induced nucleolytic degradation of the double-la-
beled fluorogenic probe that anneals to the target template at 
5 tion may be continuously monitored using detection hard-
ware, such as the model 7700 and model 7900HT Sequence 
Detection Systems, available from Applied Biosystems (Fos-
ter City, Calif.). 
The amount of dechlorinating bacteria containing the poly-
l O nucleotide sequence of interest, present in the sample may be 
determined using RTm PCR, by comparing the results of the 
RTm PCR assay described above to a calibration curve. A 
calibration curve (log DNA concentration versus arbitrarily 
15 
set cycle threshold value, Cr) may be obtained using serial 
dilutions of DNA of known concentration. The Cr values 
obtained for each sample may be compared with the standard 
curve to determine the DNA concentration of Dehalococ-
co ides. Using an average molecular weight of 660 for a base a site between the two primer recognition sequences (see, 
e.g., U.S. Pat. No. 6,387,652). 20 pair in dsDNA, one reductive dehalogenase gene operon per 
Dehalococcoides genome, and a genome size of 1.5 Mbp 
(www.tigr.org), the following equation may be used to ascer-
tain the number of Dehalococcoides-derived reductive deha-
The measurement of the released fluorescent emission fol-
lowing each round of PCR amplification (Heid et al., (1996) 
Genome Research, 6:986-994) thus forms the basis for quan-
tifying the amount of target nucleic acid present in a sample at 
the initiation of the PCRreaction. Since the exponential accu-
mulation of the fluorescent signal directly reflects the expo-
nential accumulation of the PCR amplification product, this 
reaction is monitored in real time. Hardware, such as the 
model 7700 and model 7900HT Sequence Detection Sys-
tems, available from Applied Biosystems (Foster City, Calif.) 30 
can be used to automate the detection and quantitative mea-
surement of these signals, which are stoichiometrically 
related to the quantities of amplicons produced. From the 
output data of the RTm PCR, quantification from a reliable 
back calculation to the input target DNA sequence is possible 35 
using standard curves generated with known amounts oftem-
plate DNA. 
logenase gene copies that were present in the DNA obtained 
25 from 1 ml of the dechlorinating enrichment culture: 
Primers and probes useful in RTm PCR identification and 
quantification of a bacteria population having a polynucle-
otide sequence of interest may be designed to correspond to 40 
the polynucleotide of interest. In one embodiment of the 
present invention, primers and probes useful in RTm PCR 
correspond to regions of the bvcA genes identified herein. 
Primers useful in the present embodiment include, but are not 
limited to, those having the polynucleotide sequence of any 45 
one of SEQ ID NO: 9-22. Useful RTm PCR probes include, 
but are not limited to, those polynucleotide which hybridize 
to any one SEQ ID NO: 1-8. In a preferred embodiment, the 
PCR primer pair and probe for use in RTm PCR consist of a 
first (forward) primer having the polynucleotide sequence of 50 
SEQ ID NO: 23, a second (reverse) primer having the poly-
nucleotide sequence of SEQ ID NO: 24 and probe having the 
polynucleotide sequence of SEQ ID NO: 25. 
RTm PCR may be used to identify and quantify a popula-
tion of dechlorinating bacteria having a polynucleotide 55 
sequence of interest by first isolating DNA from a sample 
suspected of having dechlorinating activity using any one of 
the methods known in the art (see e.g., He, J. et al. (2003) 
Appl. Environ. Microbial. 65:485-495). The isolated DNA 
may be amplified using RTm PCR by contacting the sample 60 
with any one of the probes described above, and any one of the 
primer pairs described above. Preferably, the probe is fluoro-
genically labeled. For example, the probe is labeled with 
6-carboxy-fluorescein (FAM) as a reporter fluorochrome on 
the 5' end, and N,N, N',N'-tetramethyl-6-carboxy-rhodamine 65 
(TAMRA) as quencher on the 3' end. The isolated DNA 
sample is subjected to RTm PCR using any one of the RTm 
DNA (µg/ml) x 6.023 x 1023 
Reductive dehalogenase gene copies/ml= (l.S x 106 x 660
) x 106) 
EXAMPLES 
The present invention is further exemplified in the follow-
ing non-limiting Examples. Unless otherwise stated, parts 
and percentages are by weight and degrees are Celsius. As 
apparent to one of ordinary skill in the art, these Examples, 
while indicating preferred embodiments of the invention, are 
given by way of illustration only. 
Chemicals were purchased from Aldrich (Milwaukee, 
Wis.) or Sigma Chemical Co. (St Louis, Mo.), except for VC, 
which was obtained from Fluka Chemical Corp. 
(Ronkonkoma, N.Y.). Restriction enzymes were purchased 
from Promega Biosciences, Inc. (San Luis Obispo, Calif.), 
and enzymes used for cell lysis were from Sigma Chemical 
Co. PCR reagents were purchased from Applied Biosystems 
(Foster City, Calif.), and BSA was purchased from Roche 
(Mannheim, Germany). 
Example 1 
Isolation of DNA from VC-Dechlorinating Cultures 
Genomic DNA was obtained from pure cultures of Deha-
lococcoides sp. strain BAVl, and several VC-dechlorinating 
enrichment cultures derived from river sediments (the Red 
Cedar, Au Sable and Pere Marquette Rivers, all three in 
Michigan (Loffier F., et al. (2000) Appl. Environ. Microbial. 
66: 1369-137 4) and chloroethene-contaminated aquifers (the 
Minerva site in Ohio, the Hydrite Chemical site in Wisconsin, 
and the Bachman Road site in Michigan (Lenvay, J., et al. 
(2003) Environ. Sci. Tech. 37:1422-1431). 
VC-dechlorinating cultures were grown in 160-ml serum 
bottles containing 100 ml reduced basal salts medium 
amended with acetate (2 mM) as a carbon source, hydrogen 
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(0.2 mmoles) as electron donor, and VC (0.12 mmoles) as 
electron acceptor as described by He, J., et al. (2003) Nature 
424:62-65. 
Genomic DNA was also available from isolates Dehalo-
coccoides sp. strain CBDBI, Dehalococcoides sp. strain FL2, 
Dehalococcoides ethenogenes strain 195, and PCE-to-
ethene-dechlorinating mixed cultures successfully employed 
in bioaugmentation approaches in the field (Major, D., et al. 
(2002) Environ. Sci. Technol. 36:5106-5116) and Bio-
Dechlor INOCULUM (www.regenesis.com), a culture based 10 
on the Bachman Road site inoculum (Lenvay, J ., et al. (2003) 
Environ. Sci. Tech. 37:1422-1431), and the VC-to-ethene-
dechlorinating Victoria culture containing strain VS (Cupples 
A., et al. (2003) Appl. Environ. Micobiol. 69:953-959). 
15 
Example 2 
Identification of RDase Genes 
20 
RDase genes were identified by amplifying genomic DNA 
using specially designed PCR primer pairs targeted to known 
conserved regions of RDase genes. Clone libraries were 
established by cloning the resulting amplicons inE. coli. The 
sequences of the cloned gene fragments contained in the 25 
clone libaries were compared with known RDase gene 
sequences. 
Primer Design 
Multiple alignments of full-length protein and DNA 
sequences ofTceA (AAN85590, AAN85588, AAF73916A) 30 
and RDases identified from the genome of Dehalococcoides 
ethenogenes strain 195 were constructed using ClustalW and 
ClustaiX (see, e.g., Thompson, J., et al. (1997) Nucleic Acid 
Res. 25:4876-4882). Conserved amino acid sequences were 
identified and used to design degenerate PCR primers. The 35 
following conserved regions were targeted for designing for-
ward and reverse primers, respectively a di-arginine contain-
ing stretch near the amino-terminus of the RDases (i.e., 
RRXFXK) and a region in the B gene (i.e., WYEW). The 
expected size of amplicons generated with these primers 40 
ranged from 1,500-1,700 bp. The degenerate primer set used 
in this study and its target sequences are listed in Table I. 
Specific primer sets (Table 2) targeting each of the RDases 
identified in the clone libraries (see below) were designed 
using Primerquest (http://biotools.idtdna.com/Primerquest/). 45 
PCR, Cloning, and Amplicon Analysis. 
DNA from V C-dechlorinating pure and mixed cultures was 
extracted using the Qiagenmini kit (Qiagen, Valencia, Calif.) 
as described previously (He, J. et al. (2003) Nature 424:62-
65). Extracted DNA was used as template for amplification 50 
with degenerate primers RRF2 and BIR (Table I). PCR reac-
tions were performed in total volumes of 30 µl with final 
concentration of reactants as follows: GeneAmp® PCR 
buffer (Ix), MgC12 (3.0 mM), BSA (0.13 mg/ml), dNTPs 
(0.25 mM each), primers (0.5 µM each), Taq DNA poly- 55 
merase (2 units), and DNA (1-2 ng/µl). 
PCR conditions included an initial denaturation step at 94 ° 
C. for2min10 sec, followed by 30 cycles of94° C. for30 sec, 
48° C. for 45 sec, and 72° C. for 2 min 10 sec, and a final 
extension step at 72° C. for 6 min. The same conditions were 60 
used for amplification with the specific primers listed in Table 
2 except that the primer concentrations were 0.1 µM, the 
MgC12 concentration was 2.0 mM, and the annealing tem-
perature was 51° C. Amplicons generated from strain BAVI 
genomic DNA with primers RRF2 and BIR were purified 65 
using the QIAquick™ PCR purification kit (Qiagen), ligated 
into vector pCR2. I by TA cloning (TOPO or TA cloning kit, 
18 
Invitrogen, Carlsbad, Calif.), and cloned in competentE. coli 





Specific Gene ID 
Primers Primer Sequence 5 '__,.3' targeted NO 
bavrdAlF GTACCGATGATGATTCACG rdhAlBAVl 9 
bavrdAlR AGCCATACATGTCCCGCAA rdhAlBAV! 16 
bavrdA2F TGCAAGCAGGTTCCCAT rdhA2BAV! 10 
bavrdA2R GGCTTGATGTTAAACCC rdhA2BAV! 17 
bavrdA3F GATTATGCTTTGTTTGGG rdhA3BAV! 11 
bavrdA3R TTAGAACAACCACCAGGC rdhA3BAV! 18 
bavrdA4F ATGCCATGTATTCGGTC rdhA4BAVl 12 
bavrdA4R TCAACCCTCCAGCCTTTA rdhA4BAVl 19 
bavrdA5F GTTAATGTTGCCAAGGCT rdhA5BAVl 13 
bavrdA5R CATGGTCTTTTCCATATTGGC rdhA5BAVl 20 
bvcAF TGCCTCAAGTACAGGTGGT rdhA6BAV! - 14 
bvcA 
bvcAR ATTGTGGAGGACCTACCT rdhA6BAV! 21 
bvcA 
bavrdA7F AAACTGCTCAGGGTTG rdhA7BAVl 15 
bavrdA7R TTGCCCGGAACACTGTA rdhA7BAVl 22 
Recombinant E. coli clones were screened by verifying the 
correct insert size using direct PCR with primers targeting the 
pCR2. I cloning vector flanking the inserted fragment. Ampli-
cons of the predicted length were digested individually with 
the enzymes MspI and HhaI (Promega Biosciences), as per 
manufacturer recommendations for Restriction Fragment 
Length Polymorphism (RFLP) analysis. Plasmid DNA from 
recombinant clones containing the different inserts was 
extracted using the Qiaprep™ spin miniprep kit (Qiagen), 
and partially sequenced with vector specific primers using an 
ABI 3100 genetic analyzer (Applied Biosystems, Foster City, 
Calif.). 
A second clone library was established using the same 
procedure with genomic DNA from the Bachman enrichment 
culture, from which strain BAVI was isolated. Inserts of the 
predicted length were analyzed with BLAS TX to verify simi-
larity and the presence of consensus sequences indicative of 
RDase genes. Further, DNA sequences were translated using 
the TRANSLATE program (http://us.expasy.org/tools/ 
dna.html) into amino acid sequences to examine for known 
RDase motifs. Partial protein sequences were aligned using 
the programs clustalW and clustalX. The designation of 
RDase genes was adapted from Villemur, R. et al. (2002) Can. 
J. Microbial. 48:697-706. 
The degenerate primer pair RRF2 and BIR produced frag-
ments of the expected size and a total of seven clones were 
recovered in the clone library generated with DNA from the 
VC-dechlorinating Bachman mixed culture. Restriction 
analysis identified five clone types with distinct inserts, des-
ignated rdhAl-5BAvi (SEQ ID NO: 2-6). In a second clone 
library constructed with strain BAVI pure culture DNA, 54 
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clones were recovered, and two additional RDase sequences 
were identified, i.e., rdhA6BAv1(SEQ ID NO: 7) and 
rdhA7 BAVI (SEQ ID NO: 8). No clones harboringrdhA3BAV1' 
rdhA4 BAVI, or rdhA5 BAVI were identified in the second BAVI 
clone library but subsequent PCR analysis using primer pairs 5 
targeting each of the rdhAI-7 BAVI seqences, demonstrated the 
presence of all RDase fragments in isolate BAVI and in the 
Bachman mixed culture from which BAVI was isolated (see, 
He, J. et al. (2003) Nature 424:62-65). 
indicating that both genes are co-transcribed. A clone library 
generated with the PCR-amplified cDNA contained a single 
insert, and RFLP and sequence analyses of six clones con-
firmed that the cloned fragments were identical to rdhA6 BAVI 
(SEQ ID NO: 7). 
Transcription of the VC RDase found in the cDNA clone 
library was explored in more detail using the specific primer 
pair bvcAF and bvcAR (Table 2). PCR reactions using cDNA 
generated from VC-grown BAVI cultures as template yielded 
Example 3 
Expression and Analysis of RDase Genes 
RNA Isolation 
Biomass was collected by centrifugation and cell pellets 
were immediately frozen at - 70° C. All solutions used for 
RNA extraction were prepared with diethyl pyrocarbonate 
(DEPC)-treated water, free of DNases and RNases-. Total 
RNA was extracted using the RN easy extraction kit (Qiagen) 
according to the manufacturer's recommendations with the 
following modifications to enhance cell lysis and RNA yields. 
The cell pellet was suspended in I 00 µl lysozyme digestion 
buffer (30 mM Tris-HCl, I mM EDTA, pH 8.0, 15 mg/ml 
lysozyme), 20 µl proteinase K (25 mg/ml) and 10 µl achro-
mopeptidase (1,800 U/µl). The suspension was mixed and 
incubated at room temperature for 10 min, before 50 µl 0.1 % 
Triton X-100 was added, and the mixture was shaken vigor-
ously for I 0 sec. Lysis buffer RLT (350 µl, provided with the 
RNeasy extraction kit) was added, and the lysate was trans-
ferred into a MicroRNA Bead Tube (Mo Bio Laboratories, 
Carlsbad, Calif.) and shaken horizontally on a Vortex mixer at 
maximum speed for I 0 min. DNA was removed by two con-
secutive on-column treatments with RNase-free DNase 
(Qiagen) as described by the manufacturer. RNA concentra-
tions were determined spectrophotometrically at 260 nm 
using an HP 8453 photodiodearray UV/Vis spectrophotom-
eter. 
Expression Analysis of RDase Genes 
Reverse transcription PCR (RT-PCR) was performed with 
the two-step RT-PCR sensiscript kit (Qiagen). First, reverse 
transcription reactions were performed with I mM random 
hexamer primers (Promega) and 5-50 ng of extracted RNA in 
10 amplicons of the correct size, which are shown in FIG. 2 
(DNA size marker 50-2000 by (Biorad Laboratories, Her-
cules, Calif.) (lane I); BAVI cDNA (lane 2); BAVI total RNA 
(lane 3); BAVI genomic DNA (lane 4), FL2 cDNA (lane 5), 
FL2 total RNA (lane 6), FL2 genomic DNA (lane 7); H20 
15 (lane 8), plasmid DNA containing rdhA6BAVI gene fragment 
(lane 9)), and sequence analysis confirmed their identity. No 
amplicons were obtained when total RNA extracts were used 
as template, confirming that no residual genomic DNA was 
present (FIG. 2). An additional control shown in FIG. 2 
20 involved cDNA obtained from a cis-DCE-grown culture of 
Dehalococcoides sp. strainFL2. No amplicons were obtained 
with primer pair bvcAF and bvcAR, which was expected 
since strain FL2 cannot grow with VC as electron acceptor. 
Seven RDase gene fragments were identified in strain 
25 BAVI, however, rdhA6BAVI (SEQ ID NO: 7) was the only 
RDase gene fragment present in a cDNA clone library estab-
lished with total RNA obtained from VC-grown BAVI cul-
tures. PCR reactions performed with the specific primers 
listed in Table 2 and cDNA as template confirmed these 
30 findings, and amplification only occurred with the bvcAF/ 
bvcAR primer pair targeting the rdhA6 BAVI sequence. To test 
if the six other RDase genes were expressed at lower levels, 
the PCR product generated from cDNA with primer pair 
RRF2/BIR was used for a subsequent nested PCR with the 
35 specific primer pairs listed in Table 2. These analyses sug-
gested that genes contributing to fragments rdhAI BAVI (SEQ 
ID NO: 2), rdhA3 BAVI (SEQ ID NO: 4 ), rdhA4 BAVI (SEQ ID 
NO: 5), rdhA5 BAVI (SEQ ID NO: 6), and rdhA 7 BAVI (SEQ ID 
NO: 8) were also expressed, but at significantly lower levels 
40 than rdhA6BAVI (SEQ ID NO: 7). The only RDase gene not 
transcribed at detectable levels in VC-grown BAVI cells cor-
related with fragment rdhA2BAVI (SEQ ID NO: 3). 
a total volume of 20 µl for 3 hrs at 37° C. according to the 
manufacturer's recommendations. Then, PCR was per- 45 
formed with degenerate primers RRF2 and BIR (Table I) or 
with specific primers (Table 2) using the PCR conditions 
specified above. RT-PCR amplification products were exam-
ined by gel electrophoresis on 1.5% agarose gels, and ampli-
cons generated with primers RRF2 and BIR were cloned 50 
using the TOPO TA cloning kit. Recombinant E. coli clones 
were identified as described above, and the inserts were char-
acterized by restriction analysis and sequenced. For nested 
PCR, the initial amplification was performed with primers 
RRF2 and BIR, and (I µl) of the amplified product was used 55 
as template in a second round of PCR with the specific prim-
Example 4 
Chromosome Walking and Assembling the bvcA 
Coding Sequence 
To extend the reductive dehalogenase gene fragment 
rdhA6BAv1 , the TOPO Walker kit from Invitrogen (Carlsbad, 
Calif.) was used with primers 5Bfcomp (5'ACCACCTG-
TACTTGAGGCA-3'), and 5BGR (5'ACCCGACAAA-
GAACTGGTTTCG-3'), The primer binding sites are illus-
trated in FIG. 1. 
Purified genomic DNA of strain BAVI was digested with 
Pst I and Sac I for 2 hrs at 37° C. The digested DNA was 
dephosphorylated using calf alkaline phosphatase and pre-
cipitated with phenol:chloroform (I: I pH 6. 7) following the 
TOPO Walker manual. Primer extension with primer 
ers listed in Table 2. 
PCR amplification with degenerate primers RRF2 and 
BIR using cDNA obtained from VC-grown BAVI cells as 
template yielded a PCR fragment of the expected size ( ap-
proximately I, 700 bp ). In contrast, no amplification occurred 
without the RT-PCR step, confirming that all DNA was suc-
cessfully removed from the RNA preparation, and that the 
observed 1,700 by amplicon was generated from mRNA. 
Amplification of cDNA occurred with degenerate primers 
RRF2 and BIR targeting the reductase internal RRXFXK 
motif and the WYEW sequence in the B gene, respectively, 
60 5Bfcomp at an annealing temperature of 55° C. created a 3' 
overhang required for TOPO linking. TOPO linking was per-
formed as to manufacturer's recommendations, and the 
TO PO-linked DNA was then subjected to amplification with 
primer 5BGr at an annealing temperature of 57° C. Amplifi-
65 cation was verified on I% agarose gels. 
The 305 by product was purified using the Qiaquick Gel 
Extraction Kit (Qiagen) and cloned into E. coli using the 
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cloning Kit (Invitrogen). Primers Ml 3F and Ml 3R were used 
to PCR amplify the cloned fragment according to the protocol 
for 'alternative method of analysis' provided with the TOPO 
XL PCR Cloning kit. The purified PCR product containing 
the 305 by insert was sequenced using primers M13F and 
M13R. This sequence was aligned with the previously 
obtained rdhA6BAVI gene fragment sequence, and the coding 
region was determined using Frameplot. Ishikawa, J., et al. 
(1999) FEMS Microbial. Lett. 174:251-253. 
Expression Analysis of RDase Genes 
Since the fragments generated with primer pair RRF2 and 
BIR lacked approximately 30 by on the 3' end of the RDase 
genes, the rdhA6BAVI gene fragment was extended and the 
missing upstream portion of the RDase gene was obtained. 
The complete gene implicated in VC reductive dechlorination 
10 
22 
in Dehalococcoides sp. strain BAVl was designated bvcA 
(SEQ ID NO: 1 ). The translated BvcA protein sequence con-
tained the twin arginine motif (RRXFXK) in the form RRD-
FMK. The chromosomal organization of the bvcA region is 
shown in FIG. 1. The deduced coding sequence of bvcA is 
1,550 nucleotides long, which is predicted to encode a 516 
amino acid protein. A second incomplete open reading frame 
for the B gene bvcB was found 51 nucleotides downstream of 
the bvcA stop codon TAA. 
The coding sequences of the RDase gene and B gene frag-
ments were deposited in GenBank under accession numbers 
AY553222-AY553228 (SEQ ID NO: 2-8). GenBank acces-
sion number AY563562 (SEQ ID NO: 1) was assigned to the 
complete sequence of the VC reductive dehalogenase bvcA. 
The complete sequences of the isolated RDase genes and B 
gene fragments are shown in Table 3 below. 
TABLE 3 
Isolated nucleic acid sequences 
GENE, bvcA 




















Gene, rdhAlBAn (1393) 


















Gene, rdhA2BAVI (1462) 
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TABLE 3-continued 





GENE' rdhA3BAV! - ( 143 7) 


















GENE, rdhA4BAVl (1432) 


















GENE, rdhA5BAVl (1451) 


















GENE, rdhA6BAV! (1451) 
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TABLE 3-continued 








GENE, rdhA7BAVl (1533) 



















The amino acid sequence of the isolated RDase genes of the 
present invention was deduced using Translate tool 
(http,//us.expasy.org/tools/dna.html). The deduced amino acid sequences are shown 
below. 


































(SEQ ID NO, 26) 
(SEQ ID NO, 27) 
(SEQ ID NO, 28) 
(SEQ ID NO, 29) 
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TABLE 3-continued 












































(SEQ ID NO, 30) 
(SEQ ID NO, 31) 
(SEQ ID NO, 32) 
(SEQ ID NO, 33) 
Example 5 The deduced amino acid sequences shown above were 50 
aligned with other known reductive dehalogenases isolated 
from D. ethenogenes strain 195 and Dehalococcoides sp. 
strain BAVl. The sequences were aligned using clustalX 
and/or clustalW (same algorithm for both). The alignments 
are shown in FIGS. SA-SD. Identical or similar amino acids 55 
highlighted. The alignment indicates that the deduced amino 
acid sequences of the present invention share some identity 
with other known reductive dehalogenase and the similarity is 
generally confined to the two iron-sulfur binding motifs near 
the C-terminus ( (CXXCXXCXXXCP)2 ). The degree of simi- 60 
larity between the deduced amino acid sequences and other 
known reductive dehalogenases isolated from D. ethenogenes 
strain 195 and Dehalococcoides sp. strain BAVl is shown in 
the matrix represented by FIGS. 6A-6D. The degree of simi-
larity matrix was calculated using BLOSUM62 amino acid 65 
substitution matrix, Henikoff, S. and Henikoff, J. G. (1992) 
Proc. Natl. Acad. Sci. USA 89: 10915-10919. 
Detection ofbvcA in Other Dechlorinating Cultures 
PCR amplification was performed using bvcA-targeted 
primers bvcAF and bvcAR (Table 2) using genomic DNA 
from other Dehalococcoides isolates and Dehalococcoides-
containing mixed cultures as templates. As shown in FIG. 3, 
the correct sized amplicon was generated with isolate BAVl 
genomic DNA, but not with genomic DNA from Dehalococ-
coides ethenogenes strain 195, strain FL2, or strain CBDBl, 
none of which have been reported to grow on VC (FIG. 3, 
DNA size marker 50-2000 by (Biorad Laboratories, Her-
cules, Calif.) (lane 1 ); genomic DNA from: strain BAVl (lane 
2), strain CBDBl (lane 3), Dehalococcoides ethenogenes 
(lane 4), and strain FL2 (lane 5); H2 0 (lane 6), plasmid DNA 
containing rdhA6BAVI (lane 7)). bvcA was detected in four of 
eight Dehalococcoides-containing cultures capable of com-
plete reductive dechlorination and ethene production. 
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As shown in FIG. 4, bvcA was also present in cultures 
KB-1 and the Bio-Dechlor INOCULUM, two commercially 
available ethene-producing enrichment cultures that have 
been successfully used in bioaugmentation approaches. (FIG. 
4, DNA size marker !Kb plus (Invitrogen™, Carlsbad, Calif.) 
(lane 1), H2 0 (lane 2), plasmid DNA containing rdhA6BAVI 
(lane 3); genomic DNA from the Bachman enrichment cul-
ture (lane 4 ), the Au Sable culture (lane 5), the Pere Marquette 
culture (lane 6), the Red Cedar culture (lane 7), the Hydrite 
culture (lane 8), the Minerva culture (lane 9), Bio-Dechlor 10 
INOCULUM (lane 10), KB-1 (lane 11 ), and the Victoria 
culture (lane 12)). In addition, bvcA was identified in two 
ethene-producing enrichment cultures derived from chloro-
ethene-contaminated aquifer materials (i.e., the Minerva site 
and the Hydrite site). bvcA, however, was not detected in the 
Victoria culture containing Dehalococcoides sp. strain VS 
nor in three VC-dechlorinating enrichment cultures derived 
from Michigan river sediments (FIG. 4). 
********* 
Patents, patent applications, publications, product descrip-
tions, and protocols are cited throughout this application, the 
disclosures of which are incorporated herein by reference in 
their entireties for all purposes. 
SEQUENCE LISTING 
<160> NUMBER OF SEQ ID NOS, 33 
<210> SEQ ID NO 1 
<211> LENGTH, 1551 
<212> TYPE, DNA 
<213> ORGANISM, Dehalococcoides sp 
<400> SEQUENCE, 1 
atgcataatt tccattgtac gataagtagg cgagatttta tgaagggatt ggggttagcg 60 
ggagcaggga taggtgccgc gacttcagtt atgccgaatt ttcacgactt ggatgaagta 120 
atttctgctg ctagtgccga aaccagttct ttgtcgggta aatctcttaa taattttcct 180 
tggtatgtga aagaaaggga ttttgaaaat cctaccattg atatagattg gtctatactt 240 
gcgcgtaatg acggttacaa tcatcaggga gcctattggg gacctgtacc tgaaaatgga 300 
gatgataaaa ggtatcctga tcccgcggac cagtgtctta ctctaccaga aaagagagat 360 
ctttatttag cgtgggcaaa acagcaattt cctgactggg aaccaggaat taatggccat 420 
gggccaacaa gggacgaagc tttatggttt gcctcaagta caggtggtat cggtaggtat 480 
agaattcctg gt ace cage a aatgatgtcc acaatgcgtc ttgacgggtc tactggtggt 540 
tggggttatt tcaatcaacc accggcagca gtctggggag ggaaataccc aaggtgggaa 600 
ggaactcctg aagagaatac gttgatgatg cgaactgttt gtcaattttt tggttactcc 660 
agtataggtg taatgccaat caccagcaat acaaagaagc ttttttttga aaagcaaata 720 
cctttccaat ttatggctgg agatcccggt gtatttgggg gaacgggaaa tgtgcagttt 780 
gatgtcccgc tgccaaagac acctgttcca atagtctggg aggaagtcga taaagggtat 840 
tataatgacc agaaaattgt aatacccaat aaggctaact gggtattaac aatgacaatg 900 
cctttaccag aagatcgttt taaacgttct ctagggtggt cacttgacgc ttcaagtatg 960 
attgcctatc ctcagatggc ttttaatgga ggccgagttc agactttttt aaaagcactt 1020 
ggctatcaag gacttggtgg cgacgtggct atgtggggac ctggtggtgc ttttggagtt 1080 
atgagtggtc tttccgaaca aggtcgtgct gctaatgaaa tcagccccaa atacggttcg 1140 
gcaactaagg gctctaatcg attagtttgt gatttgccca tggttccgac caagccaatt 1200 
gatgctggca tacacaaatt ctgtgaaacg tgtggcattt gtacaacagt ttgtccctca 1260 
aatgctatcc aggtaggtcc tccacaatgg agtaataatc ggtgggataa tacccctggt 1320 
tatcttggtt atcgacttaa ctggggtaga tgtgttcttt gtacaaactg tgagacctat 1380 
tgcccatttt ttaacatgac taatggttct ttgattcata acgtagtcag atccacagtt 1440 
gcagctacac cggtttttaa ttcatttttc cgccaaatgg aacatacatt tggatatggt 1500 
atgaaagatg atttaaacga ttggtggaat caatcacaca agccttggta a 1551 
<210> SEQ ID NO 2 
<211> LENGTH, 1393 
<212> TYPE, DNA 
31 
<213> ORGANISM, Dehalococcoides sp 
<400> SEQUENCE, 2 
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gggagcaggt attggtaccg cagctgcaac tgcaactgcc ccaatgtttc acgaccttga 
tgaggtgatc gcttcaccct cagcagcaaa tgaaagacca tggtgggtaa aggatagaga 
attgtaccag cccacgcttg aggtagattg ggatattatg actccgccgg atggcagagt 
tagcgggcag cagactgaaa cccaaattca ctaccttgga agcgaagagg taaaaaggcg 
tttatcatcg aatataatgt ctcccaacgt tgaagccgct atcaataata caccggggaa 
aactttgcgt gaccaagcct tgggactcag ctcaattgta ccgatgatga ttcacggtat 
atctttcatg ggcccgggtc ttattcctac ccctgcaaca accggcgccc ctaaatggga 
gggtacacct gaagaaaaca gccggatggt acgcagtgtt cttacttttc tgggtgccgg 
tatggttggt tttggtgaaa tttccagcca ggagagagaa aaaatattct acacttatca 
taaacaagtc cccaacaaga ggcaggtatt tgaggatgta gatgttggct acgaaggtac 
cgataaatac gttttccctg acaggaagct ttataagata tctatgtccc tgcctatgtc 
ccgggaaatg tatcgaactt ccgacagatc ttcattacaa tttgcagcca atgtatcccg 
ttaccgtcac ttcagtatgc ttcagccggc tttccaagaa tttatcagag gtatcgggta 
tcattgttat ggctatcctg taccacaggc tggccctatg cctgcagcag ttagtgctat 
tcttaccggt ctggcggaat caagccggaa tagcgggtat tgtatctctc cggactacgg 
accggtttca ggtttcttta catttgtaac tgacttgcca gttgaaccca ctacacctat 
agatgctggt atctggcgct tttgtcagac ttgcaataag tgtgcccaaa actgtccgac 
ccaagtaatc ccttacgata aagaaccgag ttgggaactc cctacattat atggtaaacc 
ggatattatc catccttccg gcaagcggat gttctacgca aaccatatag agtgttggat 
gtactgtttt gaaggcggtt gcgggacatg tatggctaca tgtactttta atgtaaatgg 
cgcagccatg gtacatgatg tggttaaggc tacactagcc acaacttcaa tgtttaacga 
atttctgtgg aaagcggata agaccttcgg ctatggggtg aagtctgggg aagaaaaaga 
agactggtgg gatttatcct taccatcgat gggctgggat acaacttcct tctcaaaaca 
tggtggttat taa 
<210> SEQ ID NO 3 
<211> LENGTH, 1462 
<212> TYPE, DNA 
<213> ORGANISM, Dehalococcoides sp 
<220> FEATURE, 
<221> NAME/KEY, misc_feature 
<222> LOCATION, (52) .. (52) 
<223> OTHER INFORMATION, n is a, c, g, or t 
<220> FEATURE, 
<221> NAME/KEY, misc_feature 
<222> LOCATION, (1281) .. (1282) 
<223> OTHER INFORMATION, n is a, c, g, or t 
<220> FEATURE, 
<221> NAME/KEY, misc_feature 
<222> LOCATION, (1284) .. (1285) 
<223> OTHER INFORMATION, n is a, c, g, or t 

























gggtgctgca acagcttcag caccagtgtt tcatgatttg gatgaaatga tnacatctgt 60 
acctaaatct acaactcaac atgcttggtg ggtaaaagaa agagactatg aggatattac 120 
32 
US 8,278,092 B2 
33 
-continued 
tacgcctgtt gattggactg tttggtcacg acgtgaggcc ttaaagaacc cgatgccgcc 
cggttttgcc gggaattatg tgcctaaaga acaggccaga ttacagagct ttcgtaatga 
aattaaaaga ggtataactg aaaaaattcc cggtgcaact ttacgtgatt gggctctttc 
ggaagctggg cggagcaata ccacctcttc gtcatggatg gggcttgatg ttaaaccccc 
atggttatgg ggtgaagcct ctgctttacc ggttgaacct tggccagaag gtgcacccaa 
atgggaatct actccggaag ataatcttag aacggttcag gctgccggac actatttcgg 
tacgcctcag gtaggcgcca tggaaatcaa tgaacatatg attcgtatgt tcgataaaga 
tggttttgaa cataactata gtgcaagtta tgagaaaccc atgatgcgat tccgctctga 
gtggtttgaa gatattccgg ttggttttca ggatgccaat caggtaaaac atattccaaa 
atcatgtaaa tgggcggtta cttatattgc cgccaaagaa aatgcactgc agatgactta 
tggcatgcgt actggtgatc ctcaagatcc gtggtataag cgcatctttc ctttgggtta 
tacaacagga gaggcttatt ccaaagctga ttatgttaaa gtccaattta tgaaattcat 
aaaaatgttg ggttatcaaa cttattatat gggtttagcc ggtggtacaa gttcaaatag 
tcctgcagga attttctcag gtttggcaga agaggctcgc cctgcgctgg cctgttcacc 
ttattatggt aatgcggtac gtcatattgg aatcattgtt accgatatgc ctctgagtcc 
cactaagcct attgatgccg gtattgttaa tttctgcaaa gtatgcaaaa aatgtgcgga 
gacttgccct tccggcgcta ttagtatgga aactgaacaa caatgggaac ctgcttgcac 
ggggaataat cccggtcgaa aaacttggta tttggactgg tttaaatgtc gtccatgggg 
ttccccatat tattgtccca attgtcaaac agtctgccca tttaacaatc ctaacaaagc 
aattatccat aacgctgtac nnannacggc tgccaccact ccaatattta acagcttctt 
ttcatctttg gataagagct ttggttatgc tcaccagcgt tcggacgaag agcgacttaa 
ctggtggtac agggatctta atacatggca atatgatgat gtttttggta tgggcacaaa 
agatccaaaa tcttggttat ga 
<210> SEQ ID NO 4 
<211> LENGTH, 1437 
<212> TYPE, DNA 
<213> ORGANISM, Dehaloccoides sp 
























ggagcaggcc taggagcagc tgcgtccact actccggtgt ttcatgacat ggatgaactc 60 
attgcttcat ctggttttag tggttcagaa tcatattcca gatatccatg gtgggtcaaa 120 
gaagtggata agccgaccgc agagatagac tggaatctta tgaaacccta tgacatgcgt 180 
aattcagata aatgggctac cccagaactt cttgccaaat attatgctgc tcaattaaag 240 
catactaagg aatgcatact gaataaaacg cccggcagta gtctgaagga ttatgctttg 300 
tttgggggta tcaaggggtc catgatgcaa aatgtaccaa aggttggaac ccctgaaccc 360 
aatctggaat atctctatcc tacagataca cttacttcac ttggtttacc ccggtatgaa 420 
ggcacccctg aggaaaacct taaaatgtgt gctgcagcta ttcatctact cggaggccgc 480 
gatataagcg ttgtagaggt agatgataat gttaaaaagg tcctttattc gcattctgct 540 
atgctaatgg gaggaaagcc gagtagagcc attgtttggg aagacgtaga taatgcgtat 600 
gaaacaccag aaaaaatggt aattcccaac aaatgcaaat gggcgttggt gtattcatgc 660 
cctcagtctc aattatcaag gtatcgaagt gttatcatgg gcaaatttgg ggtatttgga 720 
gcatactctg atatagcagt tatggatcaa cgtctacaaa aattcctgcg tatattggga 780 
34 
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tatcagggtg ttttggatgg tttcggtggg ggcaatagca taagtagtaa ttcgggcttt 
ggggtacttg caggcagtgg tgagattggt agacatgact acgtaaattc tcccagtttt 
ggggccttga tgcggatgag tcaatttata ctaactgact tacctctagc acctactaaa 
cccattgatg cgggtatgtg gaaattctgc cagtcatgta agaaatgtgc cgatatgtgc 
ccatctgggg ctatctccaa agaggctgaa cctacttggg agcctacggg agtatggaat 
ggcactggcc gcaagcttta tccggtagat tatcccaagt gtggcccttg gaggggaatg 
cctcctggag ggattggcca tatctatgaa gcggggcctg gtggttgttc taattgccaa 
gtagtatgtg ttttcaccaa gactcctaaa gcttcaatac atgatgttat aagaccactt 
gtttccagta cctcggtctt taacagtttc tttactacac tggataaatc attccattac 
gggggggcat ttgttactcc gctgggagaa gttaatgtaa gccctgatga atggtggaac 
cgtgatctga aaacttatcc gttcaaaggc agagttatgg gagacggttg ggcatag 
<210> SEQ ID NO 5 
<211> LENGTH, 1432 
<212> TYPE, DNA 
<213> ORGANISM, Dehalococcoides sp 
<400> SEQUENCE, 5 
ttttatgaag ggcttggggt tagctggtgc gggacttggt gccgtgtcgg ctgttacgcc 
tgtctttaga gatttggatg aactaacgtc ttcagttacg gcacatccta aacgtgcctg 
gtatgtaaag gaacgagaat ttggggatat cggtatagaa attgactgga atattttgaa 
acgccgtgac acccgaggtt attcatattg gaatccgatg atttggaagc aacattatcc 
ggcttacgat atggaagctt ttaataaagc tttagacaat aagaccaaag aactctggcc 
tgattatgca gggccgacta ccagagacta ttccctgaaa aatgccatgt attcggtcgg 
gttgggatgc cctcattacc tgtacaatgt agaacagttt ggagtgacac ttccgcatcc 
tgcaccacgc ccggaagcaa ttggtatgcc caattgggcg ggtactcctg aagaaaattt 
ccagatgatt cgggctgctt ttagtcttat cggtttaggt ccttcaatag gtataaccga 
actggatgat aagagtaggc gttttgttcg ggaatataat aactgtggtc aacacataat 
atttgatgac aatataactg aaacatatcg gacggcaaat cctcccacca ttcatattcc 
ttcttcacac cggtatgtta tagctaccca caatatgggg gcagacgaga tacttcgccg 
tgctccctca accattggtg catgcacaga gtccatatcc tatgcccgtg tagcgtatgc 
caagagtttc gttgaacaat ttatccgcgg acttggctat aacgtcgtct atggtcattc 
acttcaggct gcaccagcta tggatttctg gagtggagta ggtgagcatg cccgtatggg 
gcaggtttgt gtgacacctg agaatggtgc catgatgcgt acccatgcca tcttcttcac 
cgatttacca ctctcgccta caaaaccaat tgatgctggc attactaagt tttgcgaaac 
ttgcggtatc tgtgcagaga gctgtccggt aggagccgtt ccggctaaag gagtgaaccg 
gaattgggat tctaactgtg acggccagag ctttgataat gatatcgaaa gcggcggcac 
cgaggtaatg tacaatgtac ccggctataa aggctggagg gttgacgggt ttagatgctt 
agctgattgc aatggatgca agggttcctg ccctttcaat gctattccta acgggagctt 
catccacagt ctagttaaag caaccacttc aactaccccg ctgttcaatg gtttctttac 
ccaaatggaa aaatctctcc attacggtaa acaggataaa gaccctgaat cctggtggca 





































<210> SEQ ID NO 6 
<211> LENGTH, 1451 
<212> TYPE, DNA 
37 
<213> ORGANISM, Dehalococcoides sp 
<400> SEQUENCE, 
US 8,278,092 B2 
-continued 
attttatgaa ggctttgggt ctggctggtg ccggagtcgg agcagtgtct gctgccgccc 
cggtttttca tgatgtggat gagctgactg ctccttccgg cggcgtacag aagctgccgt 
ggtgggttaa agagagggag ttcaaagatc ttacagtacc cattgactgg cagaatctgc 
ccaagatgga gggtgttttc cccatgcagg ccaagccaac cctgtcggct caggaaagat 
atgccatggg cattcccggc ggcagttcgg gtacttgggc cagccctgag caggcgcaag 
tactttttga ttacatgaaa aaggaatttc cgggatggga acccggctat gccggtctgg 
gagacaaccg gacaaccgct ctcttcatgg ccaccaaatt tatgcgtatg ggcatgtggc 
ccggtgaaat aaacatgggc ggcaacaggg ttaatgttgc caaggctatt tcagcggccg 
gaggcacggc tgctttcacc tcattcctgg gtcttcgctc aagcgaaacg ctccgcccgc 
aggatttcgg tgtaccgcgt tgggaaggca cacctgaaga aaatctgctt accttgcgtc 
aggtagtccg tttccttggc ggctgtgatg taggtgctca ggaaatggat tcagatgttt 
tcaagctttt ccatgagaaa agcggcaaga aacagctggt aatagaaaac gtagacgaag 
cggctgaaac acccaccaaa ctggtcattc ctgccaaagc caaatatatc ctccagtgga 
ctgcccgcca gccttacgaa tccaccagac gccaggccgg cgaatatgag gatgccgctg 
tatactggtc ttatcagagg ttcccctttg tcggggctat tatccaggaa tttatccacg 
ctctgggata tactgcggtt tcaacccatc tgtctggtta ccattccagt gctgtagcga 
ccttgaccgg tatgggggaa cattgccgta tgtcatcacc catcttggtt cccaaatacg 
gcgttaccaa ccgggctatg tgggtaatta tgaccgatat gcctcttatg tccactaagc 
ctatagactt tggggtgtat gacttctgca agacctgcgg tatctgtgcg gacgcctgcc 
cgttcggctt gattgaaaaa ggcgacccga cctgggaagc tactcagccg ggtagccgtc 
ccggtttcaa cggatggcgt actaatacca ccatctgtcc gcattgtccg gtctgtcaaa 
gcagttgccc ctttaatacc aatggcgacg gttcttttat acatgatttg gtcagaaaca 
cagtttctac cacccctatt ttcaacagtt tctttgccaa tatggaaaag accatgggat 
acggacgcaa ggacccgcgc gactggtgga atatagatga ttatacctac ggtataaata 
catcttacta a 
<210> SEQ ID NO 7 
<211> LENGTH, 1504 
<212> TYPE, DNA 
<213> ORGANISM, Dehalococcoides sp 


























attggggtta gcgggagcag ggataggtgc cgcgacttca gttatgccga attttcacga 60 
cttggatgaa gtaatttctg ctgctagtgc cgaaaccagt tctttgtcgg gtaaatctct 120 
taataatttt ccttggtatg tgaaagaaag ggattttgaa aatcctacca ttgatataga 180 
ttggtctata cttgcgcgta atgacggtta caatcatcag ggagcctatt ggggacctgt 240 
acctgaaaat ggagatgata aaaggtatcc tgatcccgcg gaccagtgtc ttactctacc 300 
agaaaagaga gatctttatt tagcgtgggc aaaacagcaa tttcctgact gggaaccagg 360 
aattaatggc catgggccaa caagggacga agctttatgg tttgcctcaa gtacaggtgg 420 
tatcggtagg tatagaattc ctggtaccca gcaaatgatg tccacaatgc gtcttgacgg 480 
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gtctactggt ggttggggtt atttcaatca accaccggca gcagtctggg gagggaaata 
cccaaggtgg gaaggaactc ctgaagagaa tacgttgatg atgcgaactg tttgtcaatt 
ttttggttac tccagtatag gtgtaatgcc aatcaccagc aatacaaaga agcttttttt 
tgaaaagcaa atacctttcc aatttatggc tggagatccc ggtgtatttg ggggaacggg 
aaatgtgcag tttgatgtcc cgctgccaaa gacacctgtt ccaatagtct gggaggaagt 
cgataaaggg tattataatg accagaaaat tgtaataccc aataaggcta actgggtatt 
aacaatgaca atgcctttac cagaagatcg ttttaaacgt tctctagggt ggtcacttga 
cgcttcaagt atgattgcct atcctcagat ggcttttaat ggaggccgag ttcagacttt 
tttaaaagca cttggctatc aaggacttgg tggcgacgtg gctatgtggg gacctggtgg 
tgcttttgga gttatgagtg gtctttccga acaaggtcgt gctgctaatg aaatcagccc 
caaatacggt tcggcaacta agggctctaa tcgattagtt tgtgatttgc ccatggttcc 
gaccaagcca attgatgctg gcatacacaa attctgtgaa acgtgtggca tttgtacaac 
agtttgtccc tcaaatgcta tccaggtagg tcctccacaa tggagtaata atcggtggga 
taatacccct ggttatcttg gttatcgact taactggggt agatgtgttc tttgtacaaa 
ctgtgagacc tattgcccat tttttaacat gactaatggt tctttgattc ataacgtagt 
cagatccaca gttgcagcta caccggtttt taattcattt ttccgccaaa tggaacatac 
atttggatat ggtatgaaag atgatttaaa cgattggtgg aatcaatcac acaagccttg 
gtaa 
<210> SEQ ID NO 8 
<211> LENGTH, 1533 
<212> TYPE, DNA 
<213> ORGANISM, Dehalococcoides sp 
<400> SEQUENCE, 8 
atgaaggcac tcggtcttgt aggggctggt gcgggtgcgg cagcagctgt tgctccggtg 
ttcagagacc tagatgattt agtcgcttcc cccactgcaa ctttcccgcg tgcttggtgg 
attaaggaac gtgacctgtg ggatattacc accgaatatg actggaaagc tatgtcccgg 
catgatacat gtgaaaccat gtggataaaa cattcatggg caaaatatgt aggtgttgac 
aaggttaaag aagctgccgc cagtgcagcc gcaatcaaaa aagaagctct ggaaactggt 
aaaccgggca tggacttaag agcaactgcc ctgggtagta cctctggttt gtataatgct 
cctcaaccgt atttctcata tactaaaact gctcagggtt ggggtggtgg taagagtttc 
accggtcaat ctaccataaa agggcctgat gtactgggag tacccaagtg gcagggtgat 
cctgatgcta acctcaggat gttgcgagcg gctttacgct tctatggcgc tgcccagatt 
ggcgtagttc cctacgatac aaatgtaaag aataaattaa cctgtgttcg cgaaggtggc 
atggcctcta tgagcgataa atacattgaa aaatggccta tacccgctgt agatgcccgt 
ccgtttgtgt tcgaagatgt tgaaaaaggc tatgaaaccg ctgaaaagct ggtgattccg 
gacaaaaagg aactttttgt ggtttcagtt attcagccta tgagccgcga aatgtggcga 
cagggtagcg gcaatttgag agtggcaact aatggtcacc gttatagtct ggcatctgtt 
tggcaaacca aaattcaagg cttcctgacg acccttggtt atcagggttt gggttatcct 
accagggctt atggatccat gcctactatt cctgggttta ttttctctgg tttaggtgaa 
cttgggcgtt caaataatgt ctgtttgagc cctgaatacg gttcaaccca cggatcattc 














































<210> SEQ ID NO 9 
<211> LENGTH, 19 










<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 9 
gtaccgatga tgattcacg 
<210> SEQ ID NO 10 
<211> LENGTH, 17 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 10 
tgcaagcagg ttcccat 
<210> SEQ ID NO 11 
<211> LENGTH, 18 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 11 
gattatgctt tgtttggg 
<210> SEQ ID NO 12 
<211> LENGTH, 17 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 12 
atgccatgta ttcggtc 
<210> SEQ ID NO 13 
<211> LENGTH, 18 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 13 
gttaatgttg ccaaggct 
<210> SEQ ID NO 14 
<211> LENGTH, 19 
US 8,278,092 B2 
42 
-continued 
aactgtcctt cgcagtctat ttcatatgac 1140 
aagtatgctc ccaatgttcc ggtagaatac 1200 
gatgaaccat cttgcaaaca gtggactgag 1260 
ggttcctgcg tgttcaacgt ggacaatgcc 1320 
attgctacca ccagtctctt caatggtttc 1380 
ggacttacac ctgagtctga gtggaacaat 1440 








<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 14 
tgcctcaagt acaggtggt 
<210> SEQ ID NO 15 
<211> LENGTH, 16 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 15 
aaactgctca gggttg 
<210> SEQ ID NO 16 
<211> LENGTH, 19 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 16 
agccatacat gtcccgcaa 
<210> SEQ ID NO 17 
<211> LENGTH, 17 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 17 
ggcttgatgt taaaccc 
<210> SEQ ID NO 18 
<211> LENGTH, 18 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 18 
ttagaacaac caccaggc 
<210> SEQ ID NO 19 
<211> LENGTH, 18 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 19 
tcaaccctcc agccttta 
<210> SEQ ID NO 20 
<211> LENGTH, 21 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 20 
catggtcttt tccatattgg c 










<210> SEQ ID NO 21 
<211> LENGTH, 18 
<212> TYPE, DNA 
45 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 21 
attgtggagg acctacct 
<210> SEQ ID NO 22 
<211> LENGTH, 17 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, primer 
<400> SEQUENCE, 22 
ttgcccggaa cactgta 
<210> SEQ ID NO 23 
<211> LENGTH, 23 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, forward primer 
<400> SEQUENCE, 23 
aaaagcactt ggctatcaag gac 
<210> SEQ ID NO 24 
<211> LENGTH, 19 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, reverse primer 
<400> SEQUENCE, 24 
ccaaaagcac caccaggtc 
<210> SEQ ID NO 25 
<211> LENGTH, 22 
<212> TYPE, DNA 
<213> ORGANISM, artificial 
<220> FEATURE, 
<223> OTHER INFORMATION, probe 
<400> SEQUENCE, 25 
tggtggcgac gtggctatgt gg 
<210> SEQ ID NO 26 
<211> LENGTH, 462 
<212> TYPE, PRT 
<213> ORGANISM, Dehalococcoides sp 
<400> SEQUENCE, 26 
US 8,278,092 B2 
-continued 
Gly Ala Gly Ile Gly Thr Ala Ala Ala Thr Ala Thr Ala Pro Met Phe 
1 5 10 15 
His Asp Leu Asp Glu Val Ile Ala Ser Pro Ser Ala Ala Asn Glu Arg 
20 25 30 
Pro Trp Trp Val Lys Asp Arg Glu Leu Tyr Gln Pro Thr Leu Glu Val 
35 40 45 
Asp Trp Asp Ile Met Thr Pro Pro Asp Gly Arg Val Ser Gly Gln Gln 
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-continued 
Thr Glu Thr Gln Ile His Tyr Leu Gly Ser Glu Glu Val Lys Arg Arg 
65 70 75 80 
Leu Ser Ser Asn Ile Met Ser Pro Asn Val Glu Ala Ala Ile Asn Asn 
85 90 95 
Thr Pro Gly Lys Thr Leu Arg Asp Gln Ala Leu Gly Leu Ser Ser Ile 
100 105 110 
Val Pro Met Met Ile His Gly Ile Ser Phe Met Gly Pro Gly Leu Ile 
115 120 125 
Pro Thr Pro Ala Thr Thr Gly Ala Pro Lys Trp Glu Gly Thr Pro Glu 
130 135 140 
Glu Asn Ser Arg Met Val Arg Ser Val Leu Thr Phe Leu Gly Ala Gly 
145 150 155 160 
Met Val Gly Phe Gly Glu Ile Ser Ser Gln Glu Arg Glu Lys Ile Phe 
165 170 175 
Tyr Thr Tyr His Lys Gln Val Pro Asn Lys Arg Gln Val Phe Glu Asp 
180 185 190 
Val Asp Val Gly Tyr Glu Gly Thr Asp Lys Tyr Val Phe Pro Asp Arg 
195 200 205 
Lys Leu Tyr Lys Ile Ser Met Ser Leu Pro Met Ser Arg Glu Met Tyr 
210 215 220 
Arg Thr Ser Asp Arg Ser Ser Leu Gln Phe Ala Ala Asn Val Ser Arg 
225 230 235 240 
Tyr Arg His Phe Ser Met Leu Gln Pro Ala Phe Gln Glu Phe Ile Arg 
245 250 255 
Gly Ile Gly Tyr His Cys Tyr Gly Tyr Pro Val Pro Gln Ala Gly Pro 
260 265 270 
Met Pro Ala Ala Val Ser Ala Ile Leu Thr Gly Leu Ala Glu Ser Ser 
275 280 285 
Arg Asn Ser Gly Tyr Cys Ile Ser Pro Asp Tyr Gly Pro Val Ser Gly 
290 295 300 
Phe Phe Thr Phe Val Thr Asp Leu Pro Val Glu Pro Thr Thr Pro Ile 
305 310 315 320 
Asp Ala Gly Ile Trp Arg Phe Cys Gln Thr Cys Asn Lys Cys Ala Gln 
325 330 335 
Asn Cys Pro Thr Gln Val Ile Pro Tyr Asp Lys Glu Pro Ser Trp Glu 
340 345 350 
Leu Pro Thr Leu Tyr Gly Lys Pro Asp Ile Ile His Pro Ser Gly Lys 
355 360 365 
Arg Met Phe Tyr Ala Asn His Ile Glu Cys Trp Met Tyr Cys Phe Glu 
370 375 380 
Gly Gly Cys Gly Thr Cys Met Ala Thr Cys Thr Phe Asn Val Asn Gly 
385 390 395 400 
Ala Ala Met Val His Asp Val Val Lys Ala Thr Leu Ala Thr Thr Ser 
405 410 415 
Met Phe Asn Glu Phe Leu Trp Lys Ala Asp Lys Thr Phe Gly Tyr Gly 
420 425 430 
Val Lys Ser Gly Glu Glu Lys Glu Asp Trp Trp Asp Leu Ser Leu Pro 
435 440 445 
Ser Met Gly Trp Asp Thr Thr Ser Phe Ser Lys His Gly Tyr 
450 455 460 
<210> SEQ ID NO 27 
<211> LENGTH, 485 
<212> TYPE, PRT 
48 
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<213> ORGANISM, Dehalococcoides sp. 
<220> FEATURE, 
<221> NAME/KEY, MISC_FEATURE 
<223> OTHER INFORMATION, Xaa is any amino acid 
<220> FEATURE, 
<221> NAME/KEY, misc_feature 
<222> LOCATION, (17) .. (17) 
-continued 
<223> OTHER INFORMATION, Xaa can be any amino acid 
<220> FEATURE, 
<221> NAME/KEY, misc_feature 
<222> LOCATION, (427) .. (428) 
<223> OTHER INFORMATION, Xaa can be any amino acid 
<400> SEQUENCE, 27 
Gly Ala Ala Thr Ala Ser Ala Pro Val Phe His Asp Leu Asp Glu Met 
1 5 10 15 
Xaa Thr Ser Val Pro Lys Ser Thr Thr Gln His Ala Trp Trp Val Lys 
20 25 30 
Glu Arg Asp Tyr Glu Asp Ile Thr Thr Pro Val Asp Trp Thr Val Trp 
35 40 45 
Ser Arg Arg Glu Ala Leu Lys Asn Pro Met Pro Pro Gly Phe Ala Gly 
50 55 60 
Asn Tyr Val Pro Lys Glu Gln Ala Arg Leu Gln Ser Phe Arg Asn Glu 
65 70 75 80 
Ile Lys Arg Gly Ile Thr Glu Lys Ile Pro Gly Ala Thr Leu Arg Asp 
85 90 95 
Trp Ala Leu Ser Glu Ala Gly Arg Ser Asn Thr Thr Ser Ser Ser Trp 
100 105 110 
Met Gly Leu Asp Val Lys Pro Pro Trp Leu Trp Gly Glu Ala Ser Ala 
115 120 125 
Leu Pro Val Glu Pro Trp Pro Glu Gly Ala Pro Lys Trp Glu Ser Thr 
130 135 140 
Pro Glu Asp Asn Leu Arg Thr Val Gln Ala Ala Gly His Tyr Phe Gly 
145 150 155 160 
Thr Pro Gln Val Gly Ala Met Glu Ile Asn Glu His Met Ile Arg Met 
165 170 175 
Phe Asp Lys Asp Gly Phe Glu His Asn Tyr Ser Ala Ser Tyr Glu Lys 
180 185 190 
Pro Met Met Arg Phe Arg Ser Glu Trp Phe Glu Asp Ile Pro Val Gly 
195 200 205 
Phe Gln Asp Ala Asn Gln Val Lys His Ile Pro Lys Ser Cys Lys Trp 
210 215 220 
Ala Val Thr Tyr Ile Ala Ala Lys Glu Asn Ala Leu Gln Met Thr Tyr 
225 230 235 240 
Gly Met Arg Thr Gly Asp Pro Gln Asp Pro Trp Tyr Lys Arg Ile Phe 
245 250 255 
Pro Leu Gly Tyr Thr Thr Gly Glu Ala Tyr Ser Lys Ala Asp Tyr Val 
260 265 270 
Lys Val Gln Phe Met Lys Phe Ile Lys Met Leu Gly Tyr Gln Thr Tyr 
275 280 285 
Tyr Met Gly Leu Ala Gly Gly Thr Ser Ser Asn Ser Pro Ala Gly Ile 
290 295 300 
Phe Ser Gly Leu Ala Glu Glu Ala Arg Pro Ala Leu Ala Cys Ser Pro 
305 310 315 320 
Tyr Tyr Gly Asn Ala Val Arg His Ile Gly Ile Ile Val Thr Asp Met 
325 330 335 
Pro Leu Ser Pro Thr Lys Pro Ile Asp Ala Gly Ile Val Asn Phe Cys 
340 345 350 
50 
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Lys Val Cys Lys Lys Cys Ala Glu Thr Cys Pro Ser Gly Ala Ile Ser 
355 360 365 
Met Glu Thr Glu Gln Gln Trp Glu Pro Ala Cys Thr Gly Asn Asn Pro 
370 375 380 
Gly Arg Lys Thr Trp Tyr Leu Asp Trp Phe Lys Cys Arg Pro Trp Gly 
385 390 395 400 
Ser Pro Tyr Tyr Cys Pro Asn Cys Gln Thr Val Cys Pro Phe Asn Asn 
405 410 415 
Pro Asn Lys Ala Ile Ile His Asn Ala Val Xaa Xaa Thr Ala Ala Thr 
420 425 430 
Thr Pro Ile Phe Asn Ser Phe Phe Ser Ser Leu Asp Lys Ser Phe Gly 
435 440 445 
Tyr Ala His Gln Arg Ser Asp Glu Glu Arg Leu Asn Trp Tyr Arg Asp 
450 
Leu Asn Thr Trp Gln 
465 
Pro Lys Ser Trp Leu 
485 
<210> SEQ ID NO 28 
<211> LENGTH, 478 
<212> TYPE, PRT 
455 
Tyr Asp Asp Val Phe 
470 
<213> ORGANISM, Dehalococcoides sp. 
<400> SEQUENCE, 28 
460 
Gly Met Gly Thr Lys Asp 
475 480 
Gly Ala Gly Leu Gly Ala Ala Ala Ser Thr Thr Pro Val Phe His Asp 
1 5 10 15 
Met Asp Glu Leu Ile Ala Ser Ser Gly Phe Ser Gly Ser Glu Ser Tyr 
20 25 30 
Ser Arg Tyr Pro Trp Trp Val Lys Glu Val Asp Lys Pro Thr Ala Glu 
35 40 45 
Ile Asp Trp Asn Leu Met Lys Pro Tyr Asp Met Arg Asn Ser Asp Lys 
50 55 60 
Trp Ala Thr Pro Glu Leu Leu Ala Lys Tyr Tyr Ala Ala Gln Leu Lys 
65 70 75 80 
His Thr Lys Glu Cys Ile Leu Asn Lys Thr Pro Gly Ser Ser Leu Lys 
85 90 95 
Asp Tyr Ala Leu Phe Gly Gly Ile Lys Gly Ser Met Met Gln Asn Val 
100 105 110 
Pro Lys Val Gly Thr Pro Glu Pro Asn Leu Glu Tyr Leu Tyr Pro Thr 
115 120 125 
Asp Thr Leu Thr Ser Leu Gly Leu Pro Arg Tyr Glu Gly Thr Pro Glu 
130 135 140 
Glu Asn Leu Lys Met Cys Ala Ala Ala Ile His Leu Leu Gly Gly Arg 
145 150 155 160 
Asp Ile Ser Val Val Glu Val Asp Asp Asn Val Lys Lys Val Leu Tyr 
165 170 175 
Ser His Ser Ala Met Leu Met Gly Gly Lys Pro Ser Arg Ala Ile Val 
180 185 190 
Trp Glu Asp Val Asp Asn Ala Tyr Glu Thr Pro Glu Lys Met Val Ile 
195 200 205 
Pro Asn Lys Cys Lys Trp Ala Leu Val Tyr Ser Cys Pro Gln Ser Gln 
210 215 220 
Leu Ser Arg Tyr Arg Ser Val Ile Met Gly Lys Phe Gly Val Phe Gly 
225 230 235 240 
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Ala Tyr Ser Asp Ile Ala Val Met Asp Gln Arg Leu Gln Lys Phe Leu 
245 250 255 
Arg Ile Leu Gly Tyr Gln Gly Val Leu Asp Gly Phe Gly Gly Gly Asn 
260 265 270 
Ser Ile Ser Ser Asn Ser Gly Phe Gly Val Leu Ala Gly Ser Gly Glu 
275 280 285 
Ile Gly Arg His Asp Tyr Val Asn Ser Pro Ser Phe Gly Ala Leu Met 
290 295 300 
Arg Met Ser Gln Phe Ile Leu Thr Asp Leu Pro Leu Ala Pro Thr Lys 
305 310 315 320 
Pro Ile Asp Ala Gly Met Trp Lys Phe Cys Gln Ser Cys Lys Lys Cys 
325 330 335 
Ala Asp Met Cys Pro Ser Gly Ala Ile Ser Lys Glu Ala Glu Pro Thr 
340 345 350 
Trp Glu Pro Thr Gly Val Trp Asn Gly Thr Gly Arg Lys Leu Tyr Pro 
355 360 365 
Val Asp Tyr Pro Lys Cys Gly Pro Trp Arg Gly Met Pro Pro Gly Gly 
370 375 380 
Ile Gly His Ile Tyr Glu Ala Gly Pro Gly Gly Cys Ser Asn Cys Gln 
385 390 395 400 
Val Val Cys Val Phe Thr Lys Thr Pro Lys Ala Ser Ile His Asp Val 
405 410 415 
Ile Arg Pro Leu Val Ser Ser Thr Ser Val Phe Asn Ser Phe Phe Thr 
420 425 430 
Thr Leu Asp Lys Ser Phe His Tyr Gly Gly Ala Phe Val Thr Pro Leu 
435 440 445 
Gly Glu Val Asn Val Ser Pro Asp Glu Trp Trp Asn Arg Asp Leu Lys 
450 455 460 
Thr Tyr Pro Phe Lys Gly Arg Val Met Gly Asp Gly Trp Ala 
465 470 475 
<210> SEQ ID NO 29 
<211> LENGTH, 472 
<212> TYPE, PRT 
<213> ORGANISM, Dehalococcoides sp. 
<400> SEQUENCE, 29 
Leu Gly Leu Ala Gly Ala Gly Leu Gly Ala Val Ser Ala Val Thr Pro 
1 5 10 15 
Val Phe Arg Asp Leu Asp Glu Leu Thr Ser Ser Val Thr Ala His Pro 
20 25 30 
Lys Arg Ala Trp Tyr Val Lys Glu Arg Glu Phe Gly Asp Ile Gly Ile 
35 40 45 
Glu Ile Asp Trp Asn Ile Leu Lys Arg Arg Asp Thr Arg Gly Tyr Ser 
50 55 60 
Tyr Trp Asn Pro Met Ile Trp Lys Gln His Tyr Pro Ala Tyr Asp Met 
65 70 75 80 
Glu Ala Phe Asn Lys Ala Leu Asp Asn Lys Thr Lys Glu Leu Trp Pro 
85 90 95 
Asp Tyr Ala Gly Pro Thr Thr Arg Asp Tyr Ser Leu Lys Asn Ala Met 
100 105 110 
Tyr Ser Val Gly Leu Gly Cys Pro His Tyr Leu Tyr Asn Val Glu Gln 
115 120 125 
Phe Gly Val Thr Leu Pro His Pro Ala Pro Arg Pro Glu Ala Ile Gly 
130 135 140 
54 
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Met Pro Asn Trp Ala Gly Thr Pro Glu Glu Asn Phe Gln Met Ile Arg 
145 150 155 160 
Ala Ala Phe Ser Leu Ile Gly Leu Gly Pro Ser Ile Gly Ile Thr Glu 
165 170 175 
Leu Asp Asp Lys Ser Arg Arg Phe Val Arg Glu Tyr Asn Asn Cys Gly 
180 185 190 
Gln His Ile Ile Phe Asp Asp Asn Ile Thr Glu Thr Tyr Arg Thr Ala 
195 200 205 
Asn Pro Pro Thr Ile His Ile Pro Ser Ser His Arg Tyr Val Ile Ala 
210 215 220 
Thr His Asn Met Gly Ala Asp Glu Ile Leu Arg Arg Ala Pro Ser Thr 
225 230 235 240 
Ile Gly Ala Cys Thr Glu Ser Ile Ser Tyr Ala Arg Val Ala Tyr Ala 
245 250 255 
Lys Ser Phe Val Glu Gln Phe Ile Arg Gly Leu Gly Tyr Asn Val Val 
260 265 270 
Tyr Gly His Ser Leu Gln Ala Ala Pro Ala Met Asp Phe Trp Ser Gly 
275 280 285 
Val Gly Glu His Ala Arg Met Gly Gln Val Cys Val Thr Pro Glu Asn 
290 295 300 
Gly Ala Met Met Arg Thr His Ala Ile Phe Phe Thr Asp Leu Pro Leu 
305 310 315 320 
Ser Pro Thr Lys Pro Ile Asp Ala Gly Ile Thr Lys Phe Cys Glu Thr 
325 330 335 
Cys Gly Ile Cys Ala Glu Ser Cys Pro Val Gly Ala Val Pro Ala Lys 
340 345 350 
Gly Val Asn Arg Asn Trp Asp Ser Asn Cys Asp Gly Gln Ser Phe Asp 
355 360 365 
Asn Asp Ile Glu Ser Gly Gly Thr Glu Val Met Tyr Asn Val Pro Gly 
370 375 380 
Tyr Lys Gly Trp Arg Val Asp Gly Phe Arg Cys Leu Ala Asp Cys Asn 
385 390 395 400 
Gly Cys Lys Gly Ser Cys Pro Phe Asn Ala Ile Pro Asn Gly Ser Phe 
405 410 415 
Ile His Ser Leu Val Lys Ala Thr Thr Ser Thr Thr Pro Leu Phe Asn 
420 425 430 
Gly Phe Phe Thr Gln Met Glu Lys Ser Leu His Tyr Gly Lys Gln Asp 
435 440 445 
Lys Asp Pro Glu Ser Trp Trp His Glu Pro Asn Ala Trp His Val Tyr 
450 455 460 
Gly Ser Asn Pro Gly Leu Leu Gly 
465 470 
<210> SEQ ID NO 30 
<211> LENGTH, 478 
<212> TYPE, PRT 
<213> ORGANISM, Dehalococcoides sp. 
<400> SEQUENCE, 30 
Leu Gly Leu Ala Gly Ala Gly Val Gly Ala Val Ser Ala Ala Ala Pro 
1 5 10 15 
Val Phe His Asp Val Asp Glu Leu Thr Ala Pro Ser Gly Gly Val Gln 
20 25 30 
Lys Leu Pro Trp Trp Val Lys Glu Arg Glu Phe Lys Asp Leu Thr Val 
35 40 45 
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Pro Ile Asp Trp Gln Asn Leu Pro Lys Met Glu Gly Val Phe Pro Met 
50 55 60 
Gln Ala Lys Pro Thr Leu Ser Ala Gln Glu Arg Tyr Ala Met Gly Ile 
65 70 75 80 
Pro Gly Gly Ser Ser Gly Thr Trp Ala Ser Pro Glu Gln Ala Gln Val 
85 90 95 
Leu Phe Asp Tyr Met Lys Lys Glu Phe Pro Gly Trp Glu Pro Gly Tyr 
100 105 110 
Ala Gly Leu Gly Asp Asn Arg Thr Thr Ala Leu Phe Met Ala Thr Lys 
115 120 125 
Phe Met Arg Met Gly Met Trp Pro Gly Glu Ile Asn Met Gly Gly Asn 
130 135 140 
Arg Val Asn Val Ala Lys Ala Ile Ser Ala Ala Gly Gly Thr Ala Ala 
145 150 155 160 
Phe Thr Ser Phe Leu Gly Leu Arg Ser Ser Glu Thr Leu Arg Pro Gln 
165 170 175 
Asp Phe Gly Val Pro Arg Trp Glu Gly Thr Pro Glu Glu Asn Leu Leu 
180 185 190 
Thr Leu Arg Gln Val Val Arg Phe Leu Gly Gly Cys Asp Val Gly Ala 
195 200 205 
Gln Glu Met Asp Ser Asp Val Phe Lys Leu Phe His Glu Lys Ser Gly 
210 215 220 
Lys Lys Gln Leu Val Ile Glu Asn Val Asp Glu Ala Ala Glu Thr Pro 
225 230 235 240 
Thr Lys Leu Val Ile Pro Ala Lys Ala Lys Tyr Ile Leu Gln Trp Thr 
245 250 255 
Ala Arg Gln Pro Tyr Glu Ser Thr Arg Arg Gln Ala Gly Glu Tyr Glu 
260 265 270 
Asp Ala Ala Val Tyr Trp Ser Tyr Gln Arg Phe Pro Phe Val Gly Ala 
275 280 285 
Ile Ile Gln Glu Phe Ile His Ala Leu Gly Tyr Thr Ala Val Ser Thr 
290 295 300 
His Leu Ser Gly Tyr His Ser Ser Ala Val Ala Thr Leu Thr Gly Met 
305 310 315 320 
Gly Glu His Cys Arg Met Ser Ser Pro Ile Leu Val Pro Lys Tyr Gly 
325 330 335 
Val Thr Asn Arg Ala Met Trp Val Ile Met Thr Asp Met Pro Leu Met 
340 345 350 
Ser Thr Lys Pro Ile Asp Phe Gly Val Tyr Asp Phe Cys Lys Thr Cys 
355 360 365 
Gly Ile Cys Ala Asp Ala Cys Pro Phe Gly Leu Ile Glu Lys Gly Asp 
370 375 380 
Pro Thr Trp Glu Ala Thr Gln Pro Gly Ser Arg Pro Gly Phe Asn Gly 
385 390 395 400 
Trp Arg Thr Asn Thr Thr Ile Cys Pro His Cys Pro Val Cys Gln Ser 
405 410 415 
Ser Cys Pro Phe Asn Thr Asn Gly Asp Gly Ser Phe Ile His Asp Leu 
420 425 430 
Val Arg Asn Thr Val Ser Thr Thr Pro Ile Phe Asn Ser Phe Phe Ala 
435 440 445 
Asn Met Glu Lys Thr Met Gly Tyr Gly Arg Lys Asp Pro Arg Asp Trp 
450 455 460 
Trp Asn Ile Asp Asp Tyr Thr Tyr Gly Ile Asn Thr Ser Tyr 
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-continued 
465 470 475 
<210> SEQ ID NO 31 
<211> LENGTH, 496 
<212> TYPE, PRT 
<213> ORGANISM, Dehalococcoides sp. 
<400> SEQUENCE, 31 
Gly Ala Gly Ile Gly Ala Ala Thr Ser Val Met Pro Asn Phe His Asp 
1 5 10 15 
Leu Asp Glu Val Ile Ser Ala Ala Ser Ala Glu Thr Ser Ser Leu Ser 
20 25 30 
Gly Lys Ser Leu Asn Asn Phe Pro Trp Tyr Val Lys Glu Arg Asp Phe 
35 40 45 
Glu Asn Pro Thr Ile Asp Ile Asp Trp Ser Ile Leu Ala Arg Asn Asp 
50 55 60 
Gly Tyr Asn His Gln Gly Ala Tyr Trp Gly Pro Val Pro Glu Asn Gly 
65 70 75 80 
Asp Asp Lys Arg Tyr Pro Asp Pro Ala Asp Gln Cys Leu Thr Leu Pro 
85 90 95 
Glu Lys Arg Asp Leu Tyr Leu Ala Trp Ala Lys Gln Gln Phe Pro Asp 
100 105 110 
Trp Glu Pro Gly Ile Asn Gly His Gly Pro Thr Arg Asp Glu Ala Leu 
115 120 125 
Trp Phe Ala Ser Ser Thr Gly Gly Ile Gly Arg Tyr Arg Ile Pro Gly 
130 135 140 
Thr Gln Gln Met Met Ser Thr Met Arg Leu Asp Gly Ser Thr Gly Gly 
145 150 155 160 
Trp Gly Tyr Phe Asn Gln Pro Pro Ala Ala Val Trp Gly Gly Lys Tyr 
165 170 175 
Pro Arg Trp Glu Gly Thr Pro Glu Glu Asn Thr Leu Met Met Arg Thr 
180 185 190 
Val Cys Gln Phe Phe Gly Tyr Ser Ser Ile Gly Val Met Pro Ile Thr 
195 200 205 
Ser Asn Thr Lys Lys Leu Phe Phe Glu Lys Gln Ile Pro Phe Gln Phe 
210 215 220 
Met Ala Gly Asp Pro Gly Val Phe Gly Gly Thr Gly Asn Val Gln Phe 
225 230 235 240 
Asp Val Pro Leu Pro Lys Thr Pro Val Pro Ile Val Trp Glu Glu Val 
245 250 255 
Asp Lys Gly Tyr Tyr Asn Asp Gln Lys Ile Val Ile Pro Asn Lys Ala 
260 265 270 
Asn Trp Val Leu Thr Met Thr Met Pro Leu Pro Glu Asp Arg Phe Lys 
275 280 285 
Arg Ser Leu Gly Trp Ser Leu Asp Ala Ser Ser Met Ile Ala Tyr Pro 
290 295 300 
Gln Met Ala Phe Asn Gly Gly Arg Val Gln Thr Phe Leu Lys Ala Leu 
305 310 315 320 
Gly Tyr Gln Gly Leu Gly Gly Asp Val Ala Met Trp Gly Pro Gly Gly 
325 330 335 
Ala Phe Gly Val Met Ser Gly Leu Ser Glu Gln Gly Arg Ala Ala Asn 
340 345 350 
Glu Ile Ser Pro Lys Tyr Gly Ser Ala Thr Lys Gly Ser Asn Arg Leu 
355 360 365 
Val Cys Asp Leu Pro Met Val Pro Thr Lys Pro Ile Asp Ala Gly Ile 
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-continued 
370 375 380 
His Lys Phe Cys Glu Thr Cys Gly Ile Cys Thr Thr Val Cys Pro Ser 
385 390 395 400 
Asn Ala Ile Gln Val Gly Pro Pro Gln Trp Ser Asn Asn Arg Trp Asp 
405 410 415 
Asn Thr Pro Gly Tyr Leu Gly Tyr Arg Leu Asn Trp Gly Arg Cys Val 
420 425 430 
Leu Cys Thr Asn Cys Glu Thr Tyr Cys Pro Phe Phe Asn Met Thr Asn 
435 440 445 
Gly Ser Leu Ile His Asn Val Val Arg Ser Thr Val Ala Ala Thr Pro 
450 455 460 
Val Phe Asn Ser Phe Phe Arg Gln Met Glu His Thr Phe Gly Tyr Gly 
465 470 475 480 
Met Lys Asp Asp Leu Asn Asp Trp Trp Asn Gln Ser His Lys Pro Trp 
485 490 495 
<210> SEQ ID NO 32 
<211> LENGTH, 507 
<212> TYPE, PRT 
<213> ORGANISM, Dehalococcoides sp. 
<400> SEQUENCE, 32 
Leu Gly Leu Val Gly Ala Gly Ala Gly Ala Ala Ala Ala Val Ala Pro 
1 5 10 15 
Val Phe Arg Asp Leu Asp Asp Leu Val Ala Ser Pro Thr Ala Thr Phe 
20 25 30 
Pro Arg Ala Trp Trp Ile Lys Glu Arg Asp Leu Trp Asp Ile Thr Thr 
35 40 45 
Glu Tyr Asp Trp Lys Ala Met Ser Arg His Asp Thr Cys Glu Thr Met 
50 55 60 
Trp Ile Lys His Ser Trp Ala Lys Tyr Val Gly Val Asp Lys Val Lys 
65 70 75 80 
Glu Ala Ala Ala Ser Ala Ala Ala Ile Lys Lys Glu Ala Leu Glu Thr 
85 90 95 
Gly Lys Pro Gly Met Asp Leu Arg Ala Thr Ala Leu Gly Ser Thr Ser 
100 105 110 
Gly Leu Tyr Asn Ala Pro Gln Pro Tyr Phe Ser Tyr Thr Lys Thr Ala 
115 120 125 
Gln Gly Trp Gly Gly Gly Lys Ser Phe Thr Gly Gln Ser Thr Ile Lys 
130 135 140 
Gly Pro Asp Val Leu Gly Val Pro Lys Trp Gln Gly Asp Pro Asp Ala 
145 150 155 160 
Asn Leu Arg Met Leu Arg Ala Ala Leu Arg Phe Tyr Gly Ala Ala Gln 
165 170 175 
Ile Gly Val Val Pro Tyr Asp Thr Asn Val Lys Asn Lys Leu Thr Cys 
180 185 190 
Val Arg Glu Gly Gly Met Ala Ser Met Ser Asp Lys Tyr Ile Glu Lys 
195 200 205 
Trp Pro Ile Pro Ala Val Asp Ala Arg Pro Phe Val Phe Glu Asp Val 
210 215 220 
Glu Lys Gly Tyr Glu Thr Ala Glu Lys Leu Val Ile Pro Asp Lys Lys 
225 230 235 240 
Glu Leu Phe Val Val Ser Val Ile Gln Pro Met Ser Arg Glu Met Trp 
245 250 255 
Arg Gln Gly Ser Gly Asn Leu Arg Val Ala Thr Asn Gly His Arg Tyr 
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260 265 270 
Ser Leu Ala Ser Val Trp Gln Thr Lys Ile Gln Gly Phe Leu Thr Thr 
275 280 285 
Leu Gly Tyr Gln Gly Leu Gly Tyr Pro Thr Arg Ala Tyr Gly Ser Met 
290 295 300 
Pro Thr Ile Pro Gly Phe Ile Phe Ser Gly Leu Gly Glu Leu Gly Arg 
305 310 315 320 
Ser Asn Asn Val Cys Leu Ser Pro Glu Tyr Gly Ser Thr His Gly Ser 
325 330 335 
Phe His Phe Leu Thr Asp Leu Pro Leu Thr Pro Thr Lys Pro Ile Asp 
340 345 350 
Ala Gly Met Trp Arg Phe Cys Lys Thr Cys Ala Ile Cys Ala Glu Asn 
355 360 365 
Cys Pro Ser Gln Ser Ile Ser Tyr Asp Lys Glu Pro Ser Trp Glu Ile 
370 375 380 
Thr Pro Ser Lys Tyr Ala Pro Asn Val Pro Val Glu Tyr Ser Val Pro 
385 390 395 400 
Gly Lys Lys Val Phe Trp Arg Asp Glu Pro Ser Cys Lys Gln Trp Thr 
405 410 415 
Glu Ser Cys Gly Tyr Ser Cys Gly Ile Cys Met Gly Ser Cys Val Phe 
420 425 430 
Asn Val Asp Asn Ala Ser Met Ile His Gln Val Val Lys Gly Thr Ile 
435 440 445 
Ala Thr Thr Ser Leu Phe Asn Gly Phe Met Lys Gln Ala Asp Lys Phe 
450 455 460 
Phe Gly Tyr Gly Leu Thr Pro Glu Ser Glu Trp Asn Asn Trp Trp Asp 
465 470 475 480 
Met Asn Leu Pro Ala Tyr Ala Phe Asp Thr Thr Val Gly Val Thr Asp 
485 490 495 
Gly Gly Tyr Lys Ala Lys Gly Leu Leu Gln Gln 
500 505 
<210> SEQ ID NO 33 
<211> LENGTH, 515 
<212> TYPE, PRT 
<213> ORGANISM, Dehalococcoides sp. 
<400> SEQUENCE, 33 
Met His Asn Phe His Cys Thr Ile Ser Arg Arg Asp Phe Met Lys Gly 
1 5 10 15 
Leu Gly Leu Ala Gly Ala Gly Ile Gly Ala Ala Thr Ser Val Met Pro 
20 25 30 
Asn Phe His Asp Leu Asp Glu Val Ile Ser Ala Ala Ser Ala Glu Thr 
35 40 45 
Ser Ser Leu Ser Gly Lys Ser Leu Asn Asn Phe Pro Trp Tyr Val Lys 
50 55 60 
Glu Arg Asp Phe Glu Asn Pro Thr Ile Asp Ile Asp Trp Ser Ile Leu 
65 70 75 80 
Ala Arg Asn Asp Gly Tyr Asn His Gln Gly Ala Tyr Trp Gly Pro Val 
85 90 95 
Pro Glu Asn Gly Asp Asp Lys Arg Tyr Pro Asp Pro Ala Asp Gln Cys 
100 105 110 
Leu Thr Leu Pro Glu Lys Arg Asp Leu Tyr Leu Ala Trp Ala Lys Gln 
115 120 125 
Gln Phe Pro Asp Trp Glu Pro Gly Ile Asn Gly His Gly Pro Thr Arg 
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130 135 140 
Asp Glu Ala Leu Trp Phe Ala Ser Ser Thr Gly Gly Ile Gly Arg Tyr 
145 150 155 160 
Arg Ile Pro Gly Thr Gln Gln Met Met Ser Thr Met Arg Leu Asp Gly 
165 170 175 
Ser Thr Gly Gly Trp Gly Tyr Phe Asn Gln Pro Pro Ala Ala Val Trp 
180 185 190 
Gly Gly Lys Tyr Pro Arg Trp Glu Gly Thr Pro Glu Glu Asn Thr Leu 
195 200 205 
Met Met Arg Thr Val Cys Gln Phe Phe Gly Tyr Ser Ser Ile Gly Val 
210 215 220 
Met Pro Ile Thr Ser Asn Thr Lys Lys Leu Phe Phe Glu Lys Gln Ile 
225 230 235 240 
Pro Phe Gln Phe Met Ala Gly Asp Pro Gly Val Phe Gly Gly Thr Gly 
245 250 255 
Asn Val Gln Phe Asp Val Pro Leu Pro Lys Thr Pro Val Pro Ile Val 
260 265 270 
Trp Glu Glu Val Asp Lys Gly Tyr Tyr Asn Asp Gln Lys Ile Val Ile 
275 280 285 
Pro Asn Lys Ala Asn Trp Val Leu Thr Met Thr Met Pro Leu Pro Glu 
290 295 300 
Asp Arg Phe Lys Arg Ser Leu Gly Trp Ser Leu Asp Ala Ser Ser Met 
305 310 315 320 
Ile Ala Tyr Pro Gln Met Ala Phe Asn Gly Gly Arg Val Gln Thr Phe 
325 330 335 
Leu Lys Ala Leu Gly Tyr Gln Gly Leu Gly Gly Asp Val Ala Met Trp 
340 345 350 
Gly Pro Gly Gly Ala Phe Gly Val Met Ser Gly Leu Ser Glu Gln Gly 
355 360 365 
Arg Ala Ala Asn Glu Ile Ser Pro Lys Tyr Gly Ser Ala Thr Lys Gly 
370 375 380 
Ser Asn Arg Leu Val Cys Asp Leu Pro Met Val Pro Thr Lys Pro Ile 
385 390 395 400 
Asp Ala Gly Ile His Lys Phe Cys Glu Thr Cys Gly Ile Cys Thr Thr 
405 410 415 
Val Cys Pro Ser Asn Ala Ile Gln Val Gly Pro Pro Gln Trp Ser Asn 
420 425 430 
Asn Arg Trp Asp Asn Thr Pro Gly Tyr Leu Gly Tyr Arg Leu Asn Trp 
435 440 445 
Gly Arg Cys Val Leu Cys Thr Asn Cys Glu Thr Tyr Cys Pro Phe Phe 
450 455 460 
Asn Met Thr Asn Gly Ser Leu Ile His Asn Val Val Arg Ser Thr Val 
465 470 475 480 
Ala Ala Thr Pro Val Phe Asn Ser Phe Phe Arg Gln Met Glu His Thr 
485 490 495 
Phe Gly Tyr Gly Met Lys Asp Asp Leu Asn Asp Trp Trp Asn Gln Ser 
His Lys Pro 
515 
500 505 510 
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What we claim is: 
1. An isolated polynucleotide encoding a reductive deha-
logenase comprising a polynucleotide sequence having at 
least 95% sequence identity over the length of the entire 
reference sequence to a sequence selected from the group 5 
consisting of SEQ ID NO: 1 and SEQ ID NO: 7. 
2. The isolated polynucleotide of claim 1, wherein the 
polynucleotide is isolated from a bacterial population belong-
ing to the family Dehalococcoides. 
3. A recombinant expression vector comprising the poly- 10 
nucleotide of claim 1 operably linked to a regulatory 
68 
10. An isolated polynucleotide, wherein the polynucle-
otide comprises the sequence AAAAGCACTTGGCTAT-
CAAGGAC (SEQ ID NO: 23). 
11. The isolated polynucleotide of claim 10, wherein the 
polynucleotide has the sequence AAAAGCACTTGGCT 
ATCAAGGAC (SEQ ID NO: 23). 
12. The isolated polynucleotide of claim 10, wherein the 
polynucleotide comprises one or more of a reporter dye or a 
quencher. 
13. An isolated polynucleotide, wherein the polynucle-
otide comprises the sequence TGGTGGCGACGTGGCTAT-
GTGG (SEQ ID NO: 25). 
sequence. 
4. A cell comprising the recombinant expression vector of 
claim 3. 
14. The isolated polynucleotide of claim 13, wherein the 
polynucleotide has the sequence TGGTGGCGACGTGGC-
15 TATGTGG (SEQ ID NO: 25). 
5. An organism comprising the recombinant expression 
vector of claim 3. 
6. A vector comprising the polynucleotide of claim 1. 
15. The isolated polynucleotide of claim 13, wherein the 
polynucleotide comprises one or more of a reporter dye or a 
quencher. 
7. An isolated polynucleotide that hybridizes under highly 
stringent conditions to the isolated polynucleotide of claim 1. 
8. The isolated polynucleotide of claim 1, wherein the 
polynucleotide has the sequence consisting essentially of the 
polynucleotide of SEQ ID NO: 1. 
16. An isolated polynucleotide, wherein the polynucle-
20 otide comprises the sequence CCAAAAGCACCACCAG-
GTC (SEQ ID NO: 24). 
9. The isolated polynucleotide of claim 1, wherein the 
polynucleotide sequence has at least 99% sequence identity 25 
over the length of the entire reference sequence to a sequence 
selected from the group consisting of SEQ ID NO: 1 and SEQ 
IDNO: 7. 
17. The isolated polynucleotide of claim 16, wherein the 
polynucleotide has the sequence CCAAAAGCACCAC-
CAGGTC (SEQ ID NO: 24). 
18. The isolated polynucleotide of claim 16, wherein the 
polynucleotide comprises one or more of a reporter dye or a 
quencher. 
* * * * * 
